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ABSTRACT 
 
Crosslinking soft tissue has become more common in tissue engineering applications, 
and recent studies have demonstrated that soft tissue mechanical behavior can be directly 
altered through crosslinking, but increased understanding of how crosslinking affects 
intervertebral disc mechanical behavior is needed.  In vitro testing of bovine disc and 
motion segments was used to characterize several important aspects of disc behavior in 
response to crosslinking after both soaking and injection treatment. 
 
The first study was a comparison of different crosslinkers to determine the effect on 
tensile properties of disc tissue.  Circumferential specimens were taken from bovine 
annulus and then soak treated with an optimized crosslinking formulation or sham 
solution.  A non-contacting laser micrometer was used to measure cross sectional area, 
after which tension testing until failure was performed to determine yield strain, yield 
stress, ultimate stress, peak modulus, and resilience.  The crosslinkers were observed to 
produce different changes in the properties, with the measured properties generally 
increasing  
 
The second study used bilateral annular injections to simulate a clinically relevant 
delivery method.  The dose response of the motion segment’s neutral zone stability 
metrics against injection concentration was mapped.  Concentrations of 20 mM and less 
had no significant effects on the stability metrics.  40mM demonstrated a change in 
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neutral zone stiffness, while at least 80mM was required to significantly affect neutral 
zone length.  Thus, meaningful changes in joint neutral zone stability were demonstrated 
using clinically relevant injection and chemical formulations. 
 
The third study used combinations of biochemical and accelerated mechanical cyclic 
loading to degrade gelatin and annulus fibrosus specimens with and without genipin 
treatment.  Genipin crosslinking attenuated changes during cyclic loading to specimen 
geometry and compliance relative to control samples.  Full recovery of genipin treated 
samples appeared to be hampered, at least partially from continued crosslinking during 
the accelerated testing. 
 
The fourth study tested the effect of genipin crosslinking to resist interlamellar shearing 
of the annulus lamella.  Using a recently reported test method that shears adjacent 
lamella, crosslinked specimens were noted to have significantly higher yield force, peak 
force, and resilience compared to sham treated controls, supporting the hypothesis that 
crosslinking would increase the load bearing ability of the interface. 
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1. INTRODUCTION 
 
1.1. Scope & Cost 
Low back pain (LBP) is a common occurrence affecting an estimated 60-80% of the 
general population some time in their life 71.  Strine and Hootman 114 reported that over a 
3 month period, 34 million adults in the US (17%) reported LBP.  Further,  LBP is not 
unique to the US, with such countries reporting a LBP lifetime prevalence as Thailand 
(7%), Nepal (18%), Sweden (31%), Yugoslovia (50%), and Finland (75%) 141. 
 
Economically, LBP presents a significant burden.  'Back Problems' ranked as the 6th 
most expensive medical condition in America in 199633 and the National Institute of 
Health 114  cite back and neck problems as the leading cause of job-related disability 
costing the US over $50 billion each year.  Outside the United States, an estimated $370 
million dollars (US) was spent in the Netherlands135 on direct medical costs to treat back 
pain, with an actual cost that may have been as much as $550 million dollars (US).   
 
1.2. Understanding the Sources and Treatment of LBP 
Diagnosing the source of LBP is often confounded by the absence of obvious 
identifiable pathologies.  Fishgrund and Montgomery 37 presented the differential 
diagnosis for LBP as: deformity, fracture, disc (herniation or stenosis), infection, tumor, 
myofascial pain, intra-abdominal pain, and intrapelvic pathology.  But he then noted that 
the 'vast majority of patients with LBP' have no deformity, tumor, infection, trauma, or  
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nerve-root impingement leaving the most likely source of back pain as originating in the 
disc or as myofascial pain.  Similarly, Zhang and colleagues reported that only about 
20% of LBP cases were attributed with reasonable certainty to a pathologic or 
anatomical entity and that discogenic lower back pain (DLBP) is the most common 
disease of chronic LBP accounting for 39% of incidence 151. 
 
The underlying mechanisms that produce discogenic pain are not clear.  Unlike young, 
healthy discs, older discs often appear degenerated and although degeneration has often 
been implicated as a source of pain, several studies have found that degenerated discs are 
not always painful discs.  For example, Paajanen94 found 35% of healthy male 
volunteers without back pain had significant disc degeneration on MRI and Holt 
reported disc degeneration in 90% of adult roentgenograms but only 47% had history of 
LBP37.  Some investigators have further noted that degenerated discs often exhibit 
abnormal motion patterns under loading (clinical instability).  
 
While the hypothesis of joint instability as a mechanism of disc pain has demonstrated 
mixed success 124, 41, 74, 70 recently Dickey 32 was able to demonstrate a strong 
relationship between reported pain level and motion of the spine segments.  However, it 
is also possible that the pain associated with segmental motion pain does not arise 
exclusively from the disc.  With disc degeneration, secondary structures such as the facet 
joints and para spinal ligaments may experience increased loads to compensate for 
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reduced disc performance.  This may in turn lead to pain as the secondary structures are 
over stressed. 
 
1.3. Current Treatment Options 
Conservative treatment of back pain includes management of symptoms primarily with 
drugs, behavioral therapy, chiropractic manipulation and physical therapy.  For 
presentations with a clear pathological entity, or in cases where conservative treatment is 
insufficient, surgical intervention may be offered.  For carefully selected patient 
populations, surgical treatment has shown to provide superior outcomes compared to 
nonoperative treatment for herniation, stenosis, and spondylolisthesis 145 146 144.  During 
surgery, dissection of the vertebral bone and/or disc may be necessary and hardware 
augmentation may be used to correct deformities, maintain structural integrity of the 
joint, or to promote fusion of adjacent vertebrae.  
 
1.4. Limitations of Surgical Treatment  
As previously noted, a significant portion of back pain is discogenic in nature, and 
therefore presents without an identifiable pathology.  For such cases, Fischgrund 
observed that: 
 
'The surgical treatment of chronic LBP in the absence of deformity seldom produces 
clearly beneficial objective results.  The surgical treatment of back pain due to disc 
degeneration (discogenic pain) with spinal fusion provokes considerable controversy.’ 37.   
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In a recent review, the American Pain Society 21 reported that, for non-radicular LBP, 
fusion was ‘slightly to moderately more effective than standard (nonintensive) 
nonsurgical therapy’.  For such patients where surgical treatment may be of limited 
effectiveness, ‘Management of LBP should focus mostly on patient education, with short 
term use of acetaminophen, NSAIDs, or SMT for symptomatic relief of acute LBP, with 
the judicious addition of opioid analgesics, back exercises, behavioral therapy, or 
acupuncture for additional symptomatic relief with chronic LBP.’ 29.  For this patient 
group, an alternative treatment option, preferably one that addresses the association 
between segmental motion and pain is clearly lacking. 
 
A new and novel method to address nonspecific, chronic discogenic LBP by altering the 
number and type of molecular connections (crosslinks) between collagen fibers that 
comprise the disc annulus has been proposed55.  Crosslinks have been used to affect the 
mechanical behavior of collagen tissue in a wide variety of applications and could be 
implemented as a means to affect LBP associated with segmental motion.   
 
1.5. Previous Studies of Crosslinking 
There are several known chemical agents that will crosslink collagen.  Since these agents 
have different structures and reaction mechanisms, there may be differences in the 
properties of crosslinked tissue that result from their use.  Describing the exact chemical 
reactions that occur during in vivo crosslinking is difficult as the process depends on the 
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specific conditions (e.g. pH, temperature, steric effect, and proximity to primary and 
secondary reactants) at the time of the reaction.. 
 
At a basic level, Sundararaghaven 116 demonstrated a dose response relationship between 
the storage modulus (the elastic component of energy storage in a viscoelastic material) 
of a hydro gel and the concentration of the crosslinking agent used to treat the gel.  For 
an engineered fibrin based tissue, Bjork 15 showed a clear link between tissue modulus 
and crosslinking (by controlling UV exposure of the tissue).  Moving from synthetic 
biomaterials to natural tissues, attempts to engineer a set of implant mechanical 
properties by purposely altering the level of crosslinking has been described for tissues 
such as the cornea, pericardium, articular cartilage 76, and porcine aortic valve tissue 138.  
Recently, Wagner provided a detailed description of how glycation induced crosslinking 
affects the mechanical behavior of disc annulus tissue, complete with an elegant 
mathematical model relating the effect of glycation in the constitutive relationship 
between annular stress and strain 140, 139. 
 
Continuing to move up in scale to the intervertebral joint, Barbir 11 described changes to 
the axial tension – compression behavior of the rat disc after soaking with a crosslinking 
agent and Hedman 55 reported  differences in the flexion – extension neutral zone 
behavior of bovine and human discs also after soaking.  The neutral zone concept is used 
to describe the bimodal behavior of the disc.  At the ‘neutral’ position, the disc provides 
little resistance to rotation.  The point where rotation resistance begins to appreciably 
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increase is the limit of the neutral zone and demarks the neutral zone from the elastic 
zone.  Thus, discs with a small neutral zone will resist rotation sooner than discs with a 
larger neutral zone.  The size of the neutral zone is considered an indicator of 
intervertebral joint stability, with smaller neutral zones indicating more stable discs 95.  
Unlike Barbir and Hedman, Yerramalli 150 investigated an injection delivery into the 
nucleus of the rat disc and did not find a statistically significant effect on the axial 
tension – compression neutral zone, though they did note a 'trend toward increased 
stability'. 
 
In addition to achieving the desired change in mechanical behavior, to use crosslinking 
as a treatment option for LBP will require the effect to be sustainable for a useful time 
period while in an environment with high potential for enzymatic degradation and while 
subjected to varying mechanical stress.  Currently, reports on the sustainability of post 
crosslinking effects are scarce, especially with respect to cyclic mechanical loading.   
Sung 122 demonstrated that crosslinked porcine pericardium had increased degradation 
resistance compared to fresh tissue as measured by denaturation temperature and free 
amine content after collagenase digestion and Bigi 14 similarly demonstrated that 
increased crosslinking of gelatin based films with genipin correlated with decreased 
release of gelatin. Huang 61 demonstrated that implanted, genipin crosslinked tissue had 
comparable resistance to in vivo degradation as glutaraldehyde and epoxy fixed controls 
along with decreased inflammatory reaction.  It appears, however, that the only 
published study directly investigating resistance to mechanical degradation of 
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crosslinked tissue was by Vyavahare 138 who performed accelerated cyclic mechanical 
testing of collagen films and porcine aortic valves that were fixed with glutaraldehyde.  
The films were noted to undergo structural alterations as measured by FTIR after 5 
million cycles, and the valve cusps were noted to undergo similar changes after 50 
million cycles.   
 
1.6. Purpose 
In order to successfully implement a LBP treatment based on crosslinking of the native 
tissue, it is essential to understand how crosslinking affects the mechanical behavior of 
the disc tissue.  The research presented in the following sections demonstrates some of 
the basic mechanical properties and behavior of the disc tissue in response to 
crosslinking.  The main goals of the studies were: 
 Compare changes in the tensile mechanical response of disc tissue to commonly 
used crosslinkers under standardized conditions. 
 Describe the response of the intervertebral disc in response to a clinically 
relevant injection of a favorable crosslinker identified earlier. 
 Study the changes in degradation resistance of disc tissue in response to 
combinations of biochemically induced degradation, cyclic mechanical loading 
induced degradation, and crosslinking. 
 Study the changes in delamination resistance of crosslinked disc tissue after 
crosslinking treatment. 
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Section 2 describes the optimization of the crosslinker formulations (performed by other 
contributors) and the subsequent mechanical testing.  Using a circumferential tensile test, 
disc annulus specimens were tested with and without the optimized crosslinking 
treatments to determine changes to the mechanical properties. 
In section 3, Genipin was further explored in a more clinically relevant model by 
injecting whole motion segments and analyzing the resulting changes in clinical joint 
stability.  The dose response function of the motion segment stability to injection 
concentration was mapped along with observations of the minimum concentration 
required to affect a change in stability and the maximum change in stability that could be 
expected by using a concentration up to 10X the solubility concentration in an aqueous 
buffer at room temperature. 
 
Effects to the mechanical behavior of gelatin and disc annulus after biochemical 
degradation, cyclic mechanical compression, and crosslinking treatment with genipin 
were studied in section 4.  Large changes in geometry and compliance consistent with 
visual observations of induced degradation during cycling were noted in control 
specimens.  Biochemical degradation with trypsin increased the magnitude of the 
observed changes and genipin crosslinking attenuated the observed changes. Overnight 
unloaded soaking appeared to recover most of the mechanically induced changes to 
height and compliance, though visual observations of the tissue suggested that 
appreciable irreversible degradation had occurred. 
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Finally, Section 5 used a newly described methodology to evaluate changes in interfacial 
shear characteristics of the annulus.  Crosslinking was seen to increase the yield and 
peak forces along with resilience of the interlamellar interface. 
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2. OPTIMIZATION OF PROTEIN CROSSLINKING FORMULATIONS FOR 
THE TREATMENT OF DEGENERATIVE DISC DISEASE* 
 
2.1. Introduction 
Degenerative Disc Disease (DDD) is a debilitating chronic condition 4 with a US 
economic cost estimated at $100 billion 69. The spinal disc is an avascular tissue and its 
cells rely on diffusion and diurnal convection for exchange of nutrients and waste 
products 133. During aging, this process becomes gradually impaired 48 as the 
extracellular matrix of the disc clogs and the adjacent vertebral endplates become 
sclerotic and calcified.  Thus the oxygen content of the disc is reduced and the cells 
within become progressively more reliant on anaerobic glycolysis as a primary energy 
source. The resulting lactate production acidifies the tissue 72 and this, coupled to the 
reduced nutrient influx, results in a decline in the tissue’s ability to repair the mechanical 
damage caused by daily physiological loading and unloading. Over time the tissue’s 
ability to support these loads lessens, leading to fissure formation, stress intensification 
and loss of disc height.  Abnormal bulging of the weakened disc can impinge upon nerve 
roots, leading to the generation of pain and, in extreme cases, disc herniation. 
                                                 
* Portions of this work are reprinted with permission from "Optimization of protein 
crosslinking formulations for the treatment of degenerative disc disease" by Slusarewicz, 
P., K. Zhu, Kirking B, Toungate J, Hedman T., 2010.  Spine 36(1): E7-13. Copyright 
2010 by Wolters Kluwer Health. 
 
The contribution of this dissertation’s author is limited to the mechanical tensile and 
bulge testing, and does not include the chemical optimization of the crosslinking 
formulations. 
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Numerous treatment modalities are currently employed for the treatment of DDD 104. In 
early stages these include physical therapy and pain management with analgesics and 
anti-inflammatory agents. While these provide immediate relief, they do not prevent 
disease progression which is treated with surgical procedures of escalating severity from 
discectomy, to spinal fusion and artificial disc/nucleus implantation. However, all these 
therapies are aimed at treating the symptoms of the disease and not to remedying its 
underlying cause – the degeneration of the disc itself.  
 
Biological approaches aimed at preventing or reversing degeneration have been 
suggested, including gene, stem-cell and cytokine therapy 2,82,109. All these approaches, 
however, are faced with the harsh environment of the pathological disc which is itself 
not conducive for optimal cellular viability. 
 
It has also been suggested that disc repair and stabilization might be achieved, not 
biologically, but chemically22,55. Such non-surgical exogenous crosslinking therapy 
(NEXT) offers a promising non-surgical treatment for both retarding the progression and 
ameliorating the symptoms of DDD. It has been shown that chemical crosslinking of 
disc tissue leads to an increase in a number of important parameters such as 
proteoglycan retention, tissue strength, fatigue and tear resistance, joint stability, and a 
concomitant decrease in disc bulge (and therefore potentially neural compression) under 
load23,55,140,150. Furthermore, crosslinking of collagenous matrices can increase their 
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permeability16,26 and, since this can occur within the intervertebral disc54, crosslinking 
might reverse the decline in disc cell viability and so facilitate more effective tissue 
repair. 
 
Numerous chemical crosslinkers have been utilized to modify collagen matrices, such as 
glutaraldehyde57, proanthrocyanidins50, 1-ethyl-3-(3-dimethylaminopropyl)-carbodiim 
45, threose 137, genipin(GP) 122 and methylglyoxal (MG) 140.  We have recently 
characterized the kinetics of these chemical crosslinkers with regard to their ability to 
crosslink bovine annulus fibrosus tissue 107. Less understood is how different 
crosslinkers may affect different changes in mechanical properties of the tissue.  
Differences in the in mechanical properties after crosslinking treatment may arise from 
differences in the chemical bond proper 86 or from differences in the reaction mechanics 
that lead to differences in the resulting crosslink network 66.  We selected GP and MG as 
reagents for further optimization in this study based on their previous use in the area of 
biomechanics16,26,45,50,54,57,118,122,137,140,150 and their relatively low toxicity98,121. 
 
In order for NEXT to be viable, crosslinkers should be capable of diffusing within the 
tissue following injection and be active within the environment of the degenerating disc. 
In this paper, we investigate the diffusion rate of genipin in spinal discs and optimize 
prototype formulations containing either genipin or methylglyoxal, then compare the 
mechanical circumferential tensile test properties of bovine annulus after treatment with 
each formulation. 
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2.2. Materials and Methods 
Genipin was obtained from Challenge Bioproducts Co., Ltd. (Taiwan). All other 
reagents were from Sigma. Bovine 4-6 month old lumbar intervertebral disc tissue was 
obtained frozen and thawed at room temperature prior to use. While having similar 
cross-sectional area as human discs, calf discs have less disc height and are notably non-
degenerated.  The relative uniformity of these discs leads to minimization of variability 
in properties. 
2.2.1. Diffusion Studies 
GP was selected as a representative chemical crosslinker for these studies because its 
crosslinked adducts turn blue in the presence of oxygen129,130 25;26, and can be readily 
visualized. GP (15mM) was dissolved in phosphate-buffered saline (PBS) and 200μl 
injected into the discs of individual calf lumbar motion segments, with a 22-gauge 
needle at a depth of 1cm in the left and right lateral regions, and incubated at 37oC for 1, 
3 or 6 hours. The discs were then transected and both halves frozen at -20oC overnight to 
facilitate the color development of the genipin crosslinked products. Samples were 
thawed and photographed with a reference scale and the photographs imported into 
ImageJ software (NIH). Following normalization to the scale, the areas were measured 
manually by drawing around each zone. In most cases both surfaces of the transected 
disc were measured, though in a few samples where the cut was too close to the endplate 
this was not possible. The average of three measurements for each face was used to 
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determine the area of the diffusion zone in mm2. Differences between injectates were 
analyzed using a T-test. 
 
In experiments using surfactants 15mM GP was formulated in either PBS alone or PBS 
containing 0.1% (w/v) of either SDS or Tween-20. Solutions were injected and analyzed 
as described above. 
2.2.2. Reagent Optimization 
GP and MG were selected for further development since they are both relatively small 
molecules and substantially less toxic than glutaraldehyde 91,98,121, a commonly used 
crosslinking reagent in the field of tissue engineering. 
 
Approximately 3-5g of frozen bovine annulus was cut into 1-2mm2 pieces and 
homogenized in a 50ml Falcon tube in 4oC distilled  water using a homogenizer fitted 
with a 10mm stainless steel, saw toothed generator probe. The temperature of the 
suspension did not exceed 25oC. After 1-2 minutes large particles were allowed to settle 
and the fine suspension was decanted into a fresh tube. The process was repeated to 
completion and the tissue harvested by centrifugation at 4500rpm for 5 minutes. Tissue 
pellets were stored at -20oC until needed. 
 
Crosslinking extent was assessed by determining the loss in sensitivity of the tissue to 
digestion by collagenase. Approximately 20-30mg aliquots of homogenized tissue were 
weighed accurately and 0.5ml of crosslinker added while one sample was treated with 
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buffer alone. Samples were shaken at 1500rpm and 37oC for 1 hour. Following 
centrifugation at 10000rpm for 2 minutes, 0.5ml of a 1mg/ml solution of type I 
collagenase from Clostridium histolyticum in Collagenase Buffer (100mM Tris pH7.5, 
10mM CaCl2) was added to the tissue pellets which were incubated as above, but for 20 
minutes. Following a second centrifugation, proteolysis was monitored using a 
colorimetric hydroxyproline assay9,13,100,102,111 to quantify the release of peptides from 
the tissue and into the final supernatant. A solution of collagenase alone was used as a 
spectrophotometer blank and the data were normalized to the results obtained from 
buffer-treated tissue. Statistical significances were determined using the T-test. 
 
Using this assay, we confirmed previous reports 88,120 that both these crosslinkers are 
most active at elevated pH 107. We therefore decided to conduct our experiments under 
alkaline conditions (pH 9). However, the degenerating human disc is an acidic 
environment 31,72  and thus is not conducive for the optimal crosslinking activity of these 
reagents. We therefore buffered our formulations in order to maintain this pH and to 
counteract the ongoing production of lactate within the degenerating disc.  
 
Tris (2-Amino-2-hydroxymethyl-propane-1,3-diol) buffer has been previously used 
clinically for the treatment of blood acidosis 67 and therefore represents a potentially 
useful buffer for this purpose. However, due to concerns that the amine group in Tris 
might react with both GP and MG and lower the efficiency of crosslinking, we decided 
to also test a second buffer, EPPS (3-[4-(2-Hydroxyethyl)-1-piperazinyl] 
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propanesulfonic acid), which lacks amines. We used subsaturating concentrations of 
both crosslinkers, which we determined using the assays described here (data not 
shown), in order to discern any positive or negative effects of the buffer on crosslinking. 
Tissue was crosslinked using 0.1mM GP or 0.4mM MG in 100mM Tris or EPPS buffer 
at pH 9. 
 
Phosphate ions stimulate the reaction of glucose with proteins, possibly by binding to the 
target at basic residues adjacent to the crosslinking site and catalyzing the conversion of 
Schiff base intermediates to stable ketoamine products 131,142. Since glucose and MG 
participate in advanced glycation end product crosslink formation via Maillard-type 
reactions 30,131, we decided to investigate whether phosphate could stimulate crosslinking 
in our system. Samples were incubated at pH 8 with 1mM GP or 2mM MG at pH 9 or 
with 0.1mM GP or 0.4mM MG in either 100mM EPPS buffer or 100mM EPPS buffer 
containing 100mM tri-sodium phosphate.  
2.2.3. Mechanical Testing 
For circumferential tensile testing, 58 circumferential specimens of annulus were cut 
from 29 bovine lumbar discs, further cut to narrow a central region. The tensile tests of 
circumferential annulus specimens were conducted before our observations that Tris 
exhibited an inhibitory effect on crosslinking and we therefore soaked the tissue at pH 9 
in either 10mM GP in 100mM Tris/tri-sodium phosphate or 20mM MG in 100mM 
EPPS/tri-sodium phosphate at 37°C for 4-hours, or in either buffer alone.  Additionally, 
using kinetic optimizations described previously107, tissue samples were also prepared 
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using N-Ethyl-N’-(3-dimethylaminopropyl carbodiimide) (5mM EDC, 100mM MES, 
pH 6) , Glutaraldehyde (.05% GA by weight, 100mM sodium phosphate, 100mM EPPS, 
pH 9), and Proanthrocyanidin (.1% by weight, 100mM Tris, pH 8).  A description of 
each cross-linker is given below: 
 
Glutaraldehyde (Figure 1) C5H8O2 , mw=100.11582g/mol has an aldehyde structure and 
a reaction rate half life of <5 min at pH of 8-9 107.  At alkaline pH, GA reacts with 
amines on the collagen (see figure below) creating a Schiff’s base 147.  It can 
homopolymerize and form complex aldehyde-amine chain copolymers.  
 
 
 
 
Figure 1.  Structure of glutaraldehyde and formation of crosslinks in collagen35. 
 
 
1-ethyl-3-(3-dimethylaminopropyl)  carbodiimide hydrochloride (Figure 2) C8H17N3, 
mw=155.24068g/mol. Reaction occurs between both carboxyl and amine groups on the 
collagen molecule.  The product of the EDC-Carboxyl group then combines with the 
product of the EDC - amine group forming a ‘zero-length’ crosslink and urea excrete-
able products92. EDC cannot homopolymerize, but could contribute to formation of 
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amine-carboxyl based chains 127 to form complex co-polymers.  EDC has a reaction rate 
half life of <5 min at pH 6 107. 
 
 
 
Figure 2.  Structure of EDC and formation of crosslinks in collagen35 
 
 
Proanthocyanidin (Figure 3) C31H28O12, mw=592.54682 g/mol has a reaction half life of 
< 5 min at pH 5-9107.  Reaction of proanthocyanidin with collagen is thought to result in 
stable hydrogen boding with the collagen amines50. 
 
 
 
Figure 3.  Structure of Proanthocyanidin50. 
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Methylglyoxal (Figure 4) C3H4O2, mw= 72.06266 g/mol has an aldeyde structure and at 
pH 8-9, the reaction half-life is 14-20 minutes107.   
 
 
 
Figure 4.  Structure of methylglyoxal40 (left)  and proposed crosslink formation 
in collagen(right)80. 
 
 
Genipin (Figure 5) C11H14O5, mw=226.22586 g/mol has a reaction half life of 10-18 
minutes at pH 8-9107. Reaction begins with nucleophilic attack on the C3 carbon 
followed by opening of the dihydropyran ring.  Once opened, an aldehyde structure is 
formed that will react with amine groups (Figure 4) on the collagen.  The genipin dimer 
can form both homopolymers as well as copolymers with amines 129. 
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Figure 5.  Structure of genipin and crosslink formation in collagen (left,)35 and 
complex polymer formation (right)129. 
 
 
The smallest cross-section in the necked-down region of each sample was measured 
using a rotating laser micrometer. The specimen was positioned in custom clamps and a 
tensile test was run at a constant displacement rate of 0.3mm/sec.  Peak modulus, 
ultimate tensile strength, yield stress (using a 0.1% offset method), yield strain, and 
resilience (total energy absorbed at the yield point) were calculated from the stress-strain 
data. Data were expressed as the percentage change in the parameter in a treated 
specimen compared to the mean of the untreated samples. A Mann-Whitney non-
parametric test was used to determine significance of mean differences between groups 
(α≤0.05). 
 
Disc bulge measurements were conducted on twelve calf lumbar motion segments that 
were potted in polyurethane and randomly assigned to receive either an injection of 
10mM Genipin in 100mM EPPS/100mM tri-sodium phosphate, pH 9 or an injection of 
buffer alone.  Discs were injected with 0.75ml of solution at both antero-lateral positions 
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(i.e. 1.5ml per disc) using a 1ml syringe and a 22 gauge needle, and then incubated for 4-
hours at 37°C under an 89N axial load.  After incubation, specimens were clamped into 
place on a materials test system (TestResources 100R) such that the load axis was 
parallel to the specimen’s anatomical superior-inferior axis and centered on the disc’s 
center of mass.  Cyclic compressive load from 0N to 400N was applied at 0.05 mm/sec 
for 40 cycles to condition the specimen.  A rotating LK-081 laser micrometer (Keyence) 
was used to measure the anterior surface of the disc at three heights (midline and 2mm 
above and below) at static loads of 50 and 400N.  Disc surface position was analyzed for 
each applied load and at each height using custom Octave code.  Bulge was calculated as 
the difference in disc surface position at each height between the 50 and 400N loads.  
One specimen from the treatment group was 2 standard deviations away from the mean 
of the remaining samples and was discarded as an outlier.  Statistical significance was 
determined using the Mann-Whitney-test. 
 
  
 22 
 
2.3. Results 
The efficacy of NEXT will depend on a number of factors, including the ability to 
deliver the crosslinker over a large portion of the annulus and the efficiency of the 
crosslinker once introduced into the milieu of the degenerating disc. In the case of 
delivery, we first assessed the diffusion of GP, a possible therapeutic crosslinker, 
following injection into the annulus of bovine spinal discs. 
 
 
 
 
 
 
 
GP diffusion following injection formed clear “zones” (Figure 6) whose area increased 
time-dependently (Figure 7). We also examined whether two surfactants (SDS and 
Tween-20) could enhance diffusion of these markers (Figure 8), but only SDS did so 
significantly (by approximately 30%, p=0.021). We therefore decided to not pursue 
surfactants, since the effect we observed with SDS was modest and did not justify the 
added complications of its inclusion in a formulation. 
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Figure 7.  Diffusion kinetics of genipin. GP was injected into 
bovine lumbar discs and incubated for 1 (n=7), 3 (n=4) or 6 
hours (n=4) at 37oC. Data are presented ± SD. 
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Figure 6.  Example of genipin diffusion in a calf lumbar spinal disc. GP 
was injected into the disc of a single motion segment and incubated for 1 
hour at 37oC. Arrows indicate the injection points. Bars = 10mm. 
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When testing the effects of buffers on crosslinking we found that it was less efficient in 
the presence of Tris buffer when compared to EPPS (Figure 9) for both GP (p=0.0013) 
and MG (p=0.0021). Under these conditions GP crosslinking was 47% more efficient in 
EPPS while the enhancement for MG was 44%. In addition, phosphate ions increased 
crosslinking by GP by 72% at pH 8 (p<0.001) and by 44% at pH 9 (p<0.01), while MG 
was 50% more efficient at pH 8 (p<0.001) but unaffected at pH 9 (Figure 10). Such 
effects were not due to the added sodium in the mixture since tri-potassium phosphate 
caused similar effects (data not shown). 
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Figure 8. Effect of surfactants on diffusion of genipin. GP in PBS (n=7) 
or in PBS containing Tween-20 (n=3) or SDS (n=5) was injected and 
incubated for 1-hour. Data are presented ± SD.  
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Figure 10. Effect of phosphate on genipin and methylglyoxal 
mediated crosslinking. Tissue was incubated with GP or MG at 
pH 8 or 9 at 37oC for 1 hour, in the presence or absence of 
phosphate. Crosslinking was quantified and normalized to 
untreated tissue. Data are presented ± SD (n=5). 
Figure 9.  Buffers effects on genipin and methylglyoxal crosslinking. 
Tissue was incubated with GP or MG at 37oC for 1 hour in either 
Tris or EPPS buffers at pH 9. Crosslinking was quantified and 
normalized to untreated tissue. Data are presented ± SD (n=5). 
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The mechanical properties of tissues treated with crosslinker were compared to those 
treated with buffer alone using a circumferential tensile test.  GP elicited increases of 
66%, 36%, and 57% in yield stress, yield strain, and resilience or energy required to 
generate non recoverable deformation (P= 0.012, 0.048, and 0.019, respectively), to the 
annulus tissue. Peak modulus trended 23% higher with GP treatment, but this difference 
was not statistically significant. In contrast, MG treatment resulted in a 69% increase in 
modulus (P = 0.009), and trended higher in yield strain (46%) and ultimate tensile 
strength (27%), although these increases were not statistically significant. A summary of 
all our circumferential testing data is shown in Figure 11 as a percent change from each 
treatment’s respective control.  Additionally, in Table 1, the mean values of the 
circumferential tensile test properties are shown for GP and MG and their respective 
control group. 
 
Of all the crosslinkers tested, EDC showed the largest magnitude of change for all values 
except peak modulus.  EDC treated tissue yield stress was 322 % greater than controls, 
yield strain was 245 % greater*, resilience was 327 % greater, peak modulus was 131% 
greater, and UTS was 169% greater. 
 
GA treated tissue values were less than controls for all values except peak modulus.  
Yield stress was 64 % less, yield strain was 89 % less, resilience was 64 % less, and 
UTS was 79% less. Only peak modulus was greater (160%) after treatment with GA, 
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though none of the measured changes in GA were statistically significantly different 
from controls.  
 
PA showed the smallest overall magnitude in change in all values except UTS.  PA 
treated tissue yield stress was 111 % greater than controls.  Yield strain was 107 % 
greater, resilience was 111 % greater, peak modulus was 93 % less, and UTS was 120 % 
greater. None of the measured changes in PA were statistically significantly different 
than controls.   
 
We supplemented these data by measuring the effect of GP in optimized buffer with 
respect to its ability to reduce disc bulge under load following injection (a 
therapeutically more meaningful method of delivery). Specimens treated with buffer 
demonstrated a mean disc bulge of 0.28mm (±0.07) while GP reduced the value to 
0.17mm (±0.07).  This 37.5% reduction was statistically significant (p=0.04). 
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Figure 11.  Circumferential tensile mechanical properties of crosslinked annulus 
tissue. Tissue was crosslinked with genipin (GP), glutaraldehyde (GA), 
proanthrocyanidins (PA), 1-ethyl-3-(3-dimethylaminopropyl)-carbodiim (EDC), or 
methylglyoxal (MG). Data are presented as mean percentage change relative to 
sham  ± SD. * Indicates statistical significance relative to sham treatement, p<0.05. 
 
Table 1. Summary of circumferential tensile testing data. Annulus specimens were 
treated with either GP or MG, or sham-treated with the respective buffer, and then 
subjected to tensile testing. Five parameters were measured and the results are 
reported as the mean and standard deviation of each group. Units for the 
parameters are MPa (resilience, yield stress, UTS – ultimate tensile strength), 
mm/mm (yield strain) and GPa (peak modulus). Treated results marked with an 
asterisk denote a significant difference relative to the corresponding sham. 
 Resilience Yield Stress Yield Strain 
Peak 
Modulus 
UTS 
GP Sham 1.09±0.59 0.96±0.59 5.08±2.37 14.32±5.58 8.08±2.56 
GP 
Treatment 
1.71±0.80* 1.59±0.76* 6.90±2.64* 19.15±10.74 8.81±2.87 
MG Sham 1.83±1.50 1.72±1.49 5.08±2.61 9.40±3.10 6.61±3.07 
MG 
Treatment 
1.97±0.97 1.76±0.94 7.42±3.03 16.40±6.81* 8.49±2.29 
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2.4. Discussion 
NEXT holds the promise of an effective and nonsurgical treatment for DDD and would 
be accomplished by the injection of chemical crosslinking agents into the affected spinal 
disc. NEXT would act to stabilize and strengthen the disc, and promote maintenance of 
hydration and the diffusion of nutrients and oxygen into, and waste products out of, the 
tissue. 
 
We have shown GP is capable of substantial diffusion following injection into a disc 
(Figure 7) and that SDS, but not Tween-20 can enhance its diffusion (Figure 8). SDS is a 
harsh anionic surfactant and its ability to denature proteins may have “loosened” the 
annulus matrix more than the milder, non-ionic Tween-20, thus leading to faster GP 
diffusion. The harshness of SDS coupled to its relatively modest effect led us to exclude 
it from further consideration. 
 
Formulation optimization showed that GP and methylglyoxal (MG) crosslinking was 
less efficient in Tris than in EPPS buffer (Figure 9), suggesting that the use of amines 
should be avoided. We also demonstrated that phosphate ions can enhance the reaction 
of both GP and MG (Figure 10).  The inclusion of phosphate into the formulation can 
also broaden the buffering capacity of the solution (data not shown), further 
counteracting the acidity of the degenerating disc. The effect of phosphate appeared to 
be pH dependent. Since both GP and MG activities increase with pH this may have been 
due to the elevated activity masking the phosphate effect. MG activity is more sensitive 
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to pH than GP 107, and was also unaffected by phosphate at pH 9. MG’s reactivity at this 
pH may have been so high that it could not be further enhanced by phosphate. 
Nevertheless, we decided to retain phosphate in the MG formulation, since we would 
expect the pH to drop following injection into the acidic environment of the disc. 
 
The enhancement of GP-mediated crosslinking by phosphate was surprising and may be 
due to the involvement of aldehyde groups in the GP crosslinking reaction. It has been 
postulated that the initial step in the reaction involves a nucleophilic attack on the C-3 
olefinic carbon atom in GP by an amine, resulting in the opening of its dihydropyran 
ring, followed by a second attack of the attached amine on the resulting aldehyde 
group25. This second attack closes the ring with the substitution of the amine nitrogen 
(and attached moieties) for the original oxygen in the GP structure. Crosslinking then 
occurs through polymerization of the GP derivatives and the molecules to which they are 
coupled 129,130. Alternatively, the hemiacetal within the dihydropyran ring could undergo 
consecutive steps of hydration, opening the ring to produce two aldehyde groups40 
which could either react with different protein-bound amines to form a crosslink directly 
or react with a single amine and then follow the reaction described above. In either 
pathway Schiff bases form via reaction of amines with aldehydes and their 
rearrangements could be catalyzed by phosphate ions in a manner similar to those 
formed during protein glycation. 
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Using a circumferential tensile test, we examined the effect of crosslinking on annulus 
tissue using optimized buffer formulations.  As anticipated, different crosslinking agents 
were shown to produce significant differences in how they changed the tensile 
properties.  However, this study cannot explain why the different crosslinkers altered 
tensile mechanical properties in different ways.  The difference in the chemical bond has 
been suggested as an explanation for differences in the alteration of mechanical 
properties after crosslinking bovine pericardium.  While GA, GP, and MG have all been 
shown to act primarily on amine structures, EDC has been shown to react with both 
amine and carboxyl structures. Caroboxyl and amine groups are at different locations on 
the collagen molecule and that difference geometrical location may influence the 
mechanical behavior exerted by the crosslink. 
 
Others have suggested that the dynamics of the network formation influences the 
changes in mechanical properties 38.  In this study, all the formulations used were based 
on data to optimize reaction rate in homogenized tissue while the treatment of the 
mechanical test specimens was performed by soaking in solutions with an excess of 
crosslinker.  Zhu152 described the extent of crosslinking in soaked bovine annulus 
specimens using ratios of transitional enthalpies measured from differential scanning 
calorimetry (DSC).  There is a trend between the extent of crosslinking as measured by 
the ratios Zhu reported and the magnitude of changes in mechanical properties observed 
in this study, suggesting that the changes in mechanical properties were dependent on 
the extent of crosslinking achieved by the optimized formulations.  Thus, the very large 
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changes in mechanical properties observed with EDC were due to the ability of the EDC 
formulation to penetrate into the tissue and form a large number of crosslinks.  
Conversely, the lack of effect from GA was due to an inability of GA to penetrate into 
the tissue to form large numbers of crosslinks creating a highly treated zone surrounding 
a center of minimal treatment.  While GA is a relatively small molecule (MW ~ 100) 
which would imply greater access to potential crosslink sites, its high reactivity likely 
hampers crosslink formation deeper in the tissue.  
 
We also tested GP in a more clinically relevant manner by injecting the crosslinker 
directly into bovine lumbar discs using an EPPS/phosphate buffer. The GP treatment 
significantly reduced the bulge of the treated discs under a 400N axial load by 37.5% 
compared to discs injected with buffer alone and demonstrated the potential of NEXT 
when applied by injection.  The relevance towards decompression of adjacent neural 
structures (radiculopathy) and nociceptor excitation thresholds (discogenic pain) due to 
this degree of disc bulge reduction should be further explored in future studies using 
human tissues. Increases in disc bulge has been associated with increasing disc 
degeneration in the clinic 20.  It is expected that increased levels of degeneration 
combined with an increased disc height should amplify both the amount of disc bulge 
and the NEXT reduction of bulge in human discs. 
 
In order for NEXT to be therapeutically viable, it needs to exhibit an acceptable 
biocompatibility profile. Two areas of concern could be the effect of the formulation on 
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the viability of the cells of the disc and the possibility of neurotoxicity from leakage of 
crosslinkers from the disc and into the spinal canal or onto nerve roots. We are in the 
process of conducting studies to address these issues, but our preliminary data indicate 
that both formulations do not affect cell viability when injected subcutaneously (data not 
shown). 
 
Having developed suitable, optimized formulations, we next plan to determine their 
effects on a broad range of mechanical parameters of human spinal motion segments 
following injection, as a prelude to clinical testing of NEXT technology in the clinical 
setting. 
  
2.5. Conclusion 
Formulations lacking amines and containing phosphate ions appear to be promising 
candidates for clinical use of the crosslinkers genipin and methylglyoxal.  Treatments of 
bovine annulus fibrosus with commonly used crosslinker reactants formulated for 
optimal reaction rates produced changes in tensile mechanical properties that were 
unique to each reactant.  EDC produced the overall largest changes, while genipin 
produced more uniform changes to the parameters measured.
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3. THE DOSE RESPONSE RELATIONSHIP BETWEEN INTERVERTEBRAL 
DISC FLEXION-EXTENSION NEUTRAL ZONE METRICS AND INJECTED 
GENIPIN CONCENTRATION 
 
3.1. Introduction 
The intervertebral disc is a composite structure generalized as consisting of three major 
components: the nucleus, annulus fibrosus, and endplates.  In healthy discs, the nucleus 
is at the center of the disc and is a gel-like matrix of water, collagen, proteoglycans, and 
other proteins that pressurizes in response to compressive loading.  The annulus fibrosus 
surrounds the nucleus, is composed of alternating layers of obliquely aligned collagen 
fibers and restrains the pressurized nucleus.  The endplates anchor the superior and 
inferior borders of the disc to the adjacent vertebral bodies and allow nutrients to pass 
into the annulus and nucleus 4,18,28,59. 
 
Low back pain (LBP) affects an estimated 60-80% of the general population at some 
point 71 creating a substantial economic burden on Western society 33.  Degeneration of 
the disc is often associated with LBP, but is also common in pain-free individuals 58,94.  
With damage or degradation, the normal load bearing capabilities of the disc are altered 
and may result in abnormal loading and motion of the intervertebral joint.  Common 
surgical treatments for painful, degenerated and damaged discs include discectomy, 
fusion, or a combination of discectomy and fusion.  Both discectomy and fusion are 
limited in their ability to restore motion and stability of the intervertebral joint, thus great 
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efforts have been expended developing numerous partial and total disc replacements, 
some with purported regenerative potential.  However, consistent long-term clinical 
results have not been demonstrated10,43,106. 
 
Because of the limitations of discectomy, fusion, and disc replacements, these 
approaches are most often applied in cases where the disc is severely damaged or 
degraded.  Alternatively, therapies seeking to treat the native tissue in early stages of 
degradation and damage may be an effective means to slow or halt further degeneration.  
For example, when damage is mostly contained within the annulus, exogenous 
crosslinking of the damaged annulus tissue may be able to restore the mechanical 
function and load carrying abilities of disc tissue 55,108,150. Further, recent in situ studies 
have demonstrated that delivery of a crosslinking agent could be accomplished using a 
fluoroscopy guided percutaneous injection into the annulus fibrosus at the affected level 
123, similar to existing techniques developed for vertebral biopsy, discography, and 
chemonucleolysis of herniated nucleus material present in the annulus 49,73,77. If the disc 
has severe degradation of the nucleus, but mild to moderate degradation of the annulus, 
an artificial nucleus replacement device in combination with crosslinking of the native 
annulus may be sufficient to restore vertebral-disc joint function 10,42.  
 
Crosslinking collagenous soft tissues to alter their mechanical characteristics is an 
increasingly common practice and has been described for porcine aortic valve 
xenoplants 27,119,the cornea5,110, and also for hydrogels14,116.  It follows that if native soft 
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tissues contribute to the function of a joint, then crosslinking those tissues will result in 
changes to joint function.  However, the effect of such tissue alterations on joint function 
may not be obvious, nor is it obvious how much crosslinker is required to affect 
meaningful changes.  Adding further complexity, different crosslinkers demonstrate 
different mechanical effects on the same tissue 108 which may extend to different effects 
on the associated joint. 
 
For the intervertebral disc, the neutral zone is an important parameter in the 
characterization of segmental stability for the purpose of treating low back pain (LBP).  
In a clinical setting, the ability to alter the intrinsic stability of the intervertebral joint 
using an injected crosslinking agent would be an invaluable tool in the treatment of LBP.  
Two previous in-vitro studies of the disc demonstrated that crosslinking the disc by 
soaking in genipin produced changes in joint behavior:  Hedman et al 55 reported a 41% 
decrease in flexion - extension neutral zone length in bovine lumbar motion segments 
while Barbir et al 11 found a 965% increase in axial neutral zone stiffness and a 58% 
decrease in axial neutral zone length for rat motion segments.  Another study of the 
intervertebral disc which injected the nucleus pulposus with genipin did not find a 
significant difference in axial neutral zone length or stiffness, but did note that both 
parameters trended toward increased stability 150.   
 
Therefore while crosslinking the intervertebral disc by soaking in genipin has shown the 
ability to affect neutral zone motion, the ability to affect the flexion – extension neutral 
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zone with an injection mode of delivery has not been established, nor has the 
relationship between neutral zone changes and concentration of the injected genipin been 
demonstrated.  
 
This relationship between crosslinker concentration and mechanical effect has been 
characterized for gel films and the cornea 5,14,116.  Therefore, the objective of this study 
was to map the changes in the metrics of the flexion-extension neutral zone of the 
intervertebral disc with injections of increasing genipin concentration. 
 
3.2. Materials Methods 
3.2.1. Specimen Preparation 
Twenty fresh frozen bovine tail specimens were obtained from a local supplier and kept 
frozen until ready to use.  All specimens were prepared by stripping the tissue external to 
the disc and vertebrae, cutting through adjacent vertebrae and potting the hemi-vertebrae 
in cylindrical molds with fast setting, mildly exothermic, rigid urethane.  During 
preparation, potting, and subsequent testing, specimens were closely monitored, wrapped 
with moist gauze, and sprayed with a saline mist to protect against dehydration. 
 
To equalize initial hydration for the specimens, all specimens were given bilateral 0.5mL 
annular injections of phosphate buffered saline (PBS) and then wrapped in PBS-
moistened towels and placed under a 0.12 MPa axial load overnight at 4 °C.  Preliminary 
studies demonstrated that this protocol of fluid injection followed by several hours of 
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low force compression does not substantially affect the joint’s neutral zone length and 
slope during simulated flexion-extension. 
3.2.2. Treatments  
Following overnight loading, specimens were tested in flexion-extension to provide a 
baseline and then randomly administered an injection treatment with buffered (50mM 
EPPS Phosphate, pH9) genipin solution at 0, 20, 40, 80 or 400 mM using bilateral 0.5 
mL annular injections.  Each treatment group had four specimens.   The 80mM and 400 
mM genipin concentrations were greater than the solubility limit for the genipin; 
therefore DMSO was used as a cosolvent to prevent precipitation of the genipin out of 
solution. Immediately after injection, specimens were wrapped with PBS-moistened 
towels and incubated under a 0.12 MPa axial load for 4 hours at 37 °C followed by 
overnight storage under load at 4 °C.  It should be noted that the specimens were intact, 
healthy discs and this model was not intended to simulate a clinically unstable disc. 
3.2.3. Mechanical Testing   
Prior to testing, specimens were removed from the refrigerator and allowed to equilibrate 
to room temperature for at least 1 hour.  Specimens were then placed in the testing 
system (Test Resources 100R1000, Minneapolis, MN) by clamping to the inferior pot 
with the load axis of the system aligned along the anterior – posterior axis of the 
specimen as diagrammed in Figure 12.  
 
A more typical loading method described in similar testing is the direct application of a 
bending moment which may be also accompanied by a constant compressive force.   
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Advantages of a directly applied moment include having a constant moment acting 
across multiple motion segments and isolation of the mechanical behavior to loading 
components.   As the objective of this study was to investigate if injection delivery of the 
crosslinking agent could alter the mechanical behavior relative to a sham treatment 
under identical loading conditions, the traditional bending moment loading method was 
not critical; therefore, the simpler to implement shear-compression-flexion moment 
methodology was used. 
 
Specimens were cycled for 19 cycles to minimize early transient differences between 
cycles.  The loading portion of the 20th cycle was used to analyze the segment’s flexion-
extension neutral zone.  Neutral zone length and stiffness were calculated from a first 
order fit to the moment – angle data, similar to that described by Hedman et al and 
Yerramalli et al 55,150.  For this analysis, the neutral zone region was defined as the 
angular displacements for which the residual of the linear fit was less than 10% of the 
measured moment.  A graphical description of the neutral zone and the parameters used 
to characterize the neutral zone is given in Figure 13.  In addition to neutral zone 
characteristics, range of motion (ROM) and the instability score (ISS) (ISS=the neutral 
zone length divided by the product of ROM and neutral zone stiffness55) were also 
calculated. 
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Figure 12.  Schematic of the experimental setup used to simulate and measure 
intervertebral disc stability. The machine applies translation to the specimen 
through a sliding hinge and connecting rod producing flexion – extension motion of 
the motion segment (dash-dot line). 
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Figure 13.  Graphical description of neutral zone characteristics and range of 
motion.  The dash-dot line is the collected force and linear displacement data 
transformed into moment and angular displacement about the disc center.  The 
solid line is a linear fit through the data in the low stiffness region.  The end of the 
neutral zone is defined as the point where the residual between the fit and data 
reaches 10% of the peak applied moment. The slope of the fit is the neutral zone 
stiffness and the total angular displacement of the fit is the neutral zone length.  
Range of motion is defined as the total angular displacement between maximum 
and minimum applied moment. 
 
3.2.4. Statistical Analysis 
 Statistical significance of genipin injection concentration on pre-post treatment changes 
in range of motion, neutral zone length, neutral zone stiffness, and Instability Score at 
each treatment level versus the sham treatment was tested using the Kruskal Wallis 
nonparametric test.   
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3.3. Results 
The effect of genipin treatment on the flexion – extension neutral zone parameters was 
dependant on the concentration of genipin used in the treatment.  The study results are 
detailed in Table 2.  The parameters that produce the instability score (range of motion, 
neutral zone length, and neutral zone stiffness) and the instability score were all 
significantly affected by at least one genipin treatment level, p<0.005.  
 
Compared to the sham injection, changes in ROM and neutral zone length demonstrated 
significant decreases for the 80 mM and 400 mM treatment groups.  ROM decreased by 
5.7% with the 80mM injection and by 21.8% with the 400mM injection.  Neutral zone 
length decreased by 9.1% with the 80mM injection and by 26.3% with the 400mM 
injection. 
 
Neutral zone stiffness demonstrated significant increases for the 40 mM and greater 
concentrations compared to the sham injection.  At 40mM, neutral zone stiffness 
increased by 48.1% and at 80mM stiffness increased by 49.9%.  With the 400mM 
injection, neutral zone stiffness increased by 242% which was the largest change of all 
investigated variables at any treatment level.  Unexpectedly, neutral zone stiffness 
decreased with the 20mM treatment by 9.7%.  Based on the range of values and the 
trends observed in all the neutral zone parameters, the observed decrease in neutral zone 
stiffness at 20mM may indicate the amount of error in the measurements, approximately 
10%, rather than a destabilizing effect of genipin. 
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Table 2. The mean range of motion (ROM, degrees), neutral zone Length (NZ 
Length, degrees), neutral zone stiffness (NZ Stiffness, N/degree), and instability 
scores (ISS, N-1) of the bovine motion segments pre and post treatment.  Percent 
difference in each metric was calculated relative to the pretreatment value.  
Statistically significant differences (p<0.05) are shown in bold. 
 
 
In a similar manner to neutral zone stiffness, instability score did not significantly 
change relative to the sham with the 20mM injection, but did significantly change for 
injection concentrations of 40mM and greater.  At 40mM, ISS decreased by 30.0% of 
pretreatment and at 80mM ISS decreased by 31.3%.  With the 400mM injection, ISS 
decreased by 72% of the pretreatment valued.  
 
  Genipin Concentration (mM) 
 Metric 0  20  40  80  400  
Pre Trt ROM 43.6 32.0 43.3 34.8 46.0 
Post Trt ROM 46.7 34.9 45.0 32.7 35.8 
% difference ROM 7.3 9.1 4.2 -5.7 -21.8 
Pre Trt NZ Length 34.6 25.0 35.4 27.2 37.4 
Post Trt NZ Length 37.8 27.7 37.0 24.5 27.4 
% difference NZ Length 9.1 11.4 4.7 -9.1 -26.3 
Pre Trt NZ Stiffness 3.1 4.7 3.0 4.3 2.9 
Post Trt NZ Stiffness 3.2 4.2 4.3 6.1 9.5 
% difference NZ Stiffness 0.8 -9.7 48.1 49.9 242 
Pre Trt ISS 0.255 0.942 0.305 0.191 0.302 
Post Trt ISS 0.257 0.944 0.205 0.124 0.082 
% difference ISS 0.99 0.18 -30.0 -31.3 -72.0 
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3.4. Discussion 
Our study data demonstrate that annular injections to the disc with varying 
concentrations of genipin altered the flexion – extension neutral zone of the disc as 
measured by neutral zone stiffness, neutral zone length, ROM, and instability score.  
While the discs themselves were healthy and presumably clinically stable before 
treatments, the overall effect of the genipin injections on the neutral zone metrics was 
such that neutral zone stability of the disc increased with increasing genipin 
concentration.  However, the changes in the neutral zone metrics and ROM were not 
uniform across treatment concentrations.   
 
For the studied treatment amounts, none of the measured parameters demonstrated 
significant changes toward increased stability for injection treatments of 20 mM or less.  
For the 40mM treatment, the effect of the crosslinks is limited to the neutral zone 
stiffness and instability score.  With the 80mM treatment neutral zone length and ROM 
were also noticeably affected, and while stiffness was significantly different than the 
sham treatment, it wasn’t appreciably changed from the 40mM treatment.  Above 
80mM, all metrics continued to be affected by even greater amounts.   
 
At every effective concentration, the affect to neutral zone stiffness was relatively 
greater than the affect to neutral zone length or ROM.  This result agrees with an earlier 
hypothesis of Hedman et al 55, suggesting that crosslinking may reduce slack in the 
fibers so that they are more fully engaged in the low stiffness region of the motion curve: 
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“This increase in fiber tautness could be from a combination of intrinsic planar waviness 
(crimp) reduction, and/or reduction of fatigue or creep incurred non recoverable 
deformations.”  An earlier engagement of a larger percentage of fibers would have 
minimal effect outside of the neutral zone range of motion.  However this study cannot 
determine whether the greater relative effect on neutral zone stiffness compared to 
neutral zone length or ROM results from interfibril, intrafibril crosslinks, or if the 
difference is due to secondary effects such as changes in water content and flow through 
the more highly crosslinked structure.   
 
Yerramalli et al 150 reported that 100µL of 1% genipin treatment in the nucleus pulposus 
of rat motion segments “tended to increase stability” when tested in axial tension-
compression, but did not find a significant difference.  Based on the reported size of the 
rat disc (approximately 10mL), their 100µL of 1% genipin resulted in a genipin density 
of approximately 0.01 mg / ml of disc.  In comparison, bovine tail discs are on the order 
of 300mL, the necessary injection concentration needed to achieve the same genipin 
density in a bovine tail disc with a 1mL injection is approximately 10mM.  Using the 
0mM and 20mM to estimate the effect of a 10mM concentration, it appears that there 
would not be a meaningful change toward increased stability.  Therefore, the 0.01 mg/ml 
genipin density does not appear to be sufficient to alter neutral zone metrics toward 
increased stability. 
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In contrast with an injection, soaking in an excess supply of genipin should allow large 
amounts of genipin to penetrate into the disc tissue, providing sufficient soaking time.  
Using a 2 day, 0.33% genipin soak with calf lumbar motion segments, Hedman et al 55 
measured a 41% decrease in the neutral zone length.  More recently, Barbir et al 11 used 
a 12 hour soak in 1% genipin with rat discs and found a 58% decrease in tension - 
compression neutral zone length and a 965% increase in tension - compression neutral 
zone stiffness.  Compared to the present study, the highest genipin treatment produced a 
26.3% decrease in neutral zone length and a 242% increase in neutral zone stiffness, 
both of which are appreciably less than the changes observed with soaking as reported 
by Hedman and Barbir .  Therefore, bilateral, 0.5mL, 400mM genipin injections produce 
significant and substantial changes, but not as to the same degree that would be expected 
from soaking.   
 
Unlike the previously cited works by Barbir and Hedman, we used an injection delivery 
method to simulate a clinically relevant delivery mode.  Delivering larger amounts of 
genipin than are soluble in the buffer solution alone would necessitate larger fluid 
volumes, and therefore injection pressures, that would potentially damage the tissue.  
Thus, to achieve amounts of genipin that would be analogous to the previous soaking 
studies, DMSO was used to increase the genipin solubility in the buffer solution.  
Unfortunately, for both the 80mM and 400mM conditions, the addition of the DMSO to 
maintain solubility of the genipin makes it impossible to determine if the observed 
changes are strictly due to increased crosslinking with genipin, due to the DMSO, or 
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from an interaction between genipin and DMSO.  However, we know of no data 
suggesting that DMSO may act to increase stability of the disc.   
 
Additional limitations to this study would include the use of bovine tail discs which may 
not be an appropriate model for painful human discs.  The human disc data by Hedman 
et al 55 showed a larger effect of crosslinking in discs that had larger pre-treatment 
instability.  It is possible that the effects demonstrated in this study may be similarly 
magnified in unstable human discs.  Nevertheless, given that the prevalence of low back 
pain is ~15% for 18-34 year olds 114 and that there is an increase in reports of adolescent 
low back pain among Chinese school children 149, studying nondegenerated discs has 
merit.  Additionally, because nondegenerated human cadaveric disc tissue is scarce, 
bovine tissue presents a practical and lower variability alternative model. 
 
The chosen method of loading in this study, an applied anterior – posterior force to 
produce a bending moment with no independent compression component was a 
limitation associated with not having a loading system with multi-axis independent 
loading capability.  An alternative loading method, using the same single axis loading 
system, would have been to apply the force eccentrically in the superior – inferior 
direction.  That method would have required either repositioning the specimen between 
flexion-compression and extension-compression loading or alternating the applied force 
between compression (to produce flexion) and tension (to produce extension).  
Repositioning the specimen would prevent continuous cycling between flexion and 
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extension making identification and characterization of the neutral zone more difficult. 
Changing the load between compression and tension would result in asymmetric loading 
between flexion and extension.  Since shear forces on spinal segments have been linked 
to instability and pain 85,90,113, the presence of shear and compression forces coupled with 
flexion-extension moment in our chosen loading method is not unrealistic, though with 
the moment arm used in this application, the forces were small in comparison with the 
moment.  
 
Finally, this study was limited to joint flexion – extension neutral zone characteristics.  It 
is possible that other tissue and joint mechanical properties may not exhibit the same 
uniform response to increasing crosslinking concentration. 
 
3.5. Conclusion 
Injection of the disc annulus with increasing concentrations of genipin resulted in 
corresponding changes in flexion - extension neutral zone metrics as measured by the 
neutral zone slope, neutral zone length, range of motion, and instability score.  Bilateral 
0.5mL injections of 20mM genipin did not result in a significant increase in stability for 
any of the metrics.  While 40mM injections produced significant changes in neutral zone 
stiffness and instability score, 80mM injections were needed to produce significant 
changes to neutral zone length and ROM.  This study establishes the efficacy of injection 
delivery to affect disc joint mechanics and maps the dose response between injected 
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genipin and the flexion – extension neutral zone of the disc as characterized by neutral 
zone stiffness, neutral zone length, instability score, and the segment range of motion.   
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4. CHANGES IN DEGRADATION RESISTANCE OF DISC ANNULUS 
FIBROSUS AFTER CROSSLINKING 
 
4.1. Introduction 
Proposed pathways describing degradation of the intervertebral disc (IVD) have 
included, but are not limited to, mechanical, biochemical, and genetic  3,4,12,19,51,68,81.  
While these pathways have been widely reported on, few studies have combined 
multiple pathways to delineate their relative contributions as singular components or the 
contributions of the interactions between these mechanisms. 
 
The effects of biochemical degradation have been previously noted for collagenous 
tissues such as pericardia, bioprosthetic heart valves (BHVs), and articular cartilage 
34,60,101,112,115,117.  With respect to the IVD specifically, Barbir 11 demonstrated that 
collagenase and elastase significantly altered rat motion segment stiffness and neutral 
zone length after soak treatments and Kuo 75 described changes in the stiffness and 
damping coefficient of porcine motion segments after trypsin soak.  Isaacs 64 reported on 
significant changes to annulus tissue mechanical properties such as UTS, elastic 
modulus, and energy after soaking in collagenase, elastase, and Chondroitinase ABC.  
Further, the presence of collagenase, elastase, matrix metalloproteinases (MMPs), and 
trypsin have been demonstrated to correlate with in vivo disc degradation, tears 6,68,143, 
and herniation of the nucleus 53,84.   
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Similar to biochemical degradation, degradation from cyclic mechanical loading of 
collagenous tissues has been the subject of numerous studies for cartilage 25,96,125, BHVs 
101,138, and the IVD.  For the IVD, cyclic mechanical loading has been shown to alter 
motion segment height 65,78,79,134, failure stress 46,52,63, and stiffness 3,75. Callaghan 17 
demonstrated that repetitive flexion-extension of motion segments combined with axial 
loading induced herniations in human motion segments. 
 
The use of exogenous crosslinking to modulate tissue properties has been described for 
use in engineering scaffolds 76, BHVs 7, knee meniscus allografts 62, and to augment 
weakened disc annulus 23,103,108.  Exogenous formed crosslinks have been demonstrated 
to reduce degradation from enzymatic activity as well as alter tissue mechanical 
behavior.  During biochemical degradation of collagen, collagenolytic enzymes act on 
the peptide bonds to cleave the molecule into smaller units.  By preventing penetration 
into the matrix, and supporting cleaved chains, crosslinked tissue can better resist 
biochemical degradation as well as the decreases in mechanical properties associated 
with biochemical degradation92.  Mi 87 reported increased fixation indices in the knee 
meniscus after crosslinking treatments.  Resistance to degradation of pericardia with 
crosslinking was demonstrated by maintenance of denaturation temperature and ultimate 
tensile strength up to 12 weeks after subcutaneous implantation 60 and after soaking in 
collagenase 117.  In the rat intervertebral disc, Yeramalli 150 demonstrated that enzymatic 
loading decreased tension modulus, compression modulus, and neutral zone modulus, 
while increasing neutral zone length.  In contrast, genipin crosslinking of the nucleus 
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produced the opposite result but the genipin results were not statistically significant and 
control injections alone produced significant differences.  Similarly Kuo 75 reported that 
biochemical degradation of porcine motion segments with trypsin decreased the disc’s 
dynamic properties, while crosslinking treatment of trypsin degraded discs helped resist 
fatigue related changes in the disc’s dynamic properties.  However, differences in total 
injection volume between treatments make comparison of the effect sizes difficult as 
mechanical behavior of the motion segment is related to its hydration 1,56,83,89,149. 
 
In addition to increased resistance to biochemical induced degradation, crosslinking may 
also afford increased resistance to mechanically induced degradation due to the 
increased connectivity of the collagen fibers which help maintain fiber alignment as well 
as increase the number of physical bonds to distribute the loading.  BHVs demonstrate 
increased mechanical performance with increased crosslinking 7,101. At the tissue level, 
increases in mechanical properties from crosslinking 23,108,117 increase load carrying 
ability and may translate to increased fatigue resistance.  To this point, Kuo75 suggested 
that “dynamic properties of the denatured discs are better recovered by the elevated 
crosslinking”, but pre- to post-fatigue comparisons are confounded because there was no 
provision for recovery of the expelled fluid and motion segment stiffness is related to 
hydration 1,56,83,89,148.   
 
In this study, the changes to the mechanical behavior of bovine disc annulus samples 
after biochemical degradation, cyclic mechanical compression, and crosslinking 
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treatment with genipin are demonstrated.  We hypothesized that biochemical and 
mechanical degradation would alter tissue geometry and compliance and that 
crosslinking treatment would attenuate the observed degradation.  Further, we 
hypothesized that biochemical and cyclic mechanical loading may interact and produce 
changes that are not obvious from isolated study of the degradation factors. 
 
4.2. Methods 
Two experiments were performed using different material models.  The first experiment 
used cast gelatin in order to provide highly uniform samples and to ameliorate the effect 
of fluid flow through the specimen.  The second experiment used cylindrical punched 
specimens taken from the annulus of fresh frozen bovine tail discs. 
4.2.1. Experiment I: Gelatin 
Gelatin (Sigma G9382-100G) was mixed 100 mg per ml with 50mM EPPS Phosphate 
buffer ph 9 and poured into a mold to cast 20 cylinders with dimensions of 9.6 mm dia. 
X 7.9 mm tall.  Crosslinking treatment was done on 10 specimens by soaking specimens 
in 20mM GP with 50mM EPPS Phosphate buffer (ph9) at room temperature for 4 hours.  
The other 10 specimens were soaked in buffer only (sham soak) at room temperature for 
4 hours. All specimens were soaked overnight at 4C in filtered water and then for 1 hour 
at test temperature before testing. 
 
Gelatin specimens were subjected to degradation by hydrolysis, thermal, and cyclic 
mechanical loadings.  Tests were conducted in a temperature controlled PBS bath, with  
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crosslinked gelatin samples tested at 37 °C and control samples (s) tested at room 
temperature after pilot testing demonstrated that the sham treated samples degraded too 
quickly at 37 °C for testing. 
 
Mechanical degradation of the samples was done using a cyclical compressive load 
applied as a triangular wave form from 0.02N to 0.2 N at a defined strain rate of 1 
mm/sec.  At predetermined intervals, characterization of the mechanical properties was 
performed with a ramped compressive load (0.1 mm/s) to peak force of 0.2 N followed 
by returning to start position.  From the ramped loading and unloading, specimen height, 
compliance, and hysteresis were calculated.  The mass of the gelatin samples was also 
measured at each interval and used to calculate the swell ratio. 
 
Crosslinked gelatin samples were evaluated at 0, 500, 1000, 2000, 4000, 6000, and 8000 
cycles.  Control samples were only evaluated at 0, 500, and 1000 cycles after which they 
were not suitable for further testing.   
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Figure 14.  Schematic of the unconfined compression test (top) and photograph of 
untreated and treated gelatin specimens (bottom). 
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4.2.2. Experiment II: Disc Annular Tissue 
Fresh frozen bovine tail discs were removed from the vertebrae, soaked overnight in 
PBS at 4 °C and frozen.  Samples of the annulus fibrosus were punched using a 7.9mm 
diameter punch while still frozen.  Each sample appeared to contain approximately 6 to 
12 lamella.  If needed, the loading surfaces of the cylindrical samples were hand 
trimmed using a scalpel to maintain parallelism. 
 
Annulus samples were subjected to degradation by biochemical (enzymatic) and 
repetitive mechanical loadings as well as matrix augmentation by genipin crosslinking.  
There were five treatment conditions: control, genipin only, trypsin only, trypsin 
followed by genipin, and genipin followed by trypsin.  Control specimens were soaked 4 
hours in 50mM EPPS Phosphate buffer (ph9) at 37°C.  Genipin only specimens were 
soaked 4 hours in 50mM EPPS Phosphate (ph9) with 20mM genipin at 37°C.  Trypsin 
only specimens were injected with 60 µL of 0.5% Tryspin through a 28 gage needle and 
then soaked 4 hours in the same manner as controls.  The specimens in these three 
treatment groups were then stored overnight in their respective solutions at 4°C. Trypsin 
followed by genipin samples were injected and soaked overnight in the same manner as 
the trypsin only specimens, stored overnight at 4°C, then treated with genipin in the 
same manner as the genipin only specimens and stored overnight at 4°C.  Genipin 
followed by trypsin specimens were genipin soaked in the same manner as the genipin 
only specimens, stored overnight at 4°, then treated with trypsin in the same manner as 
the trypsin only samples and stored overnight at 4°C. 
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Tests were conducted in a 23°C PBS bath after allowing 1 hour for specimen 
temperature to stabilize.  The characterization of mechanical properties consisted of 
applying a ramped load at 0.1 mm/s up to 4N and then immediately returning to start 
position.  Between evaluations, samples were cyclically loaded using a triangular wave 
form from 0.4N to 4 N at a constant load rate which varied to maintain the overall 
cycling frequency of about 4 Hz. Specimens were loaded 10,000 cycles and then soaked 
unloaded in PBS overnight at 4°C.  Property characterization was done at 0, 5000, 10000 
cycles, and after overnight soaking. 
4.2.3. Data Analysis 
The data collected during the evaluation protocols was analyzed to determine the 
specimen height, hysteresis, and compliance.  Specimen height was determined from the 
platen height at the tare load during the evaluation ramp loading.   Because the disc 
annulus specimens demonstrated initial differences in height due to differences in the 
size of the disc from which they were obtained, normalized annulus height was 
calculated as the ratio to pre cycled height.  For the gelatin specimens, secant 
compliance was calculated as the change in height during the evaluation cycle divided 
by the peak force.  For the disc annulus specimens, because of the very large changes in 
height that occurred during cycling, referential secant compliance was calculated using 
the loaded height minus the pre cycled unloaded height and then normalizing by the pre 
cycled height.  Hysteresis was determined first by integrating the force displacement 
curve during the loading portion of the first evaluation cycle to determine loading energy 
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and integrating the unloading portion of the curve to determine the unloading energy.  
Hysteresis was then calculated as the difference in the loading and unloading energies. 
4.2.4. Statistics 
The percent change in the mechanical parameters within treatments was calculated and 
tested using the Wilcoxon Rank Sum nonparametric statistic for difference from the 1st 
cycle for paired samples at 10,000 cycles and after recovery soak.  Differences between 
treatments at the 1st cycle were tested using the two group Kruskal Wallis nonparametric 
test.  The software package STATA R11 was used for all statistical comparisons and 
significance was set for p<0.05 for both tests.  Because of the large number of possible 
comparisons, statistical significance was only calculated for control, genipin-only, and 
trypsin-only treatments.   
 
4.3. Results 
4.3.1. Gelatin 
Crosslinking the gelatin samples produced dramatic changes in the compliance, 
hysteresis, and swell compared to the control samples (Table 3).  Control specimens 
rapidly degraded and were unable to complete 8,000 cycles even after lowering the bath 
temperature from 37°C to 27°C.  Therefore, the control specimens were only run to 
1,000 cycles at which the percent change in height, hysteresis, swell ratio, and secant 
compliance were all statistically significantly.  Only 5 of the 8 control samples were able 
to be collected to 1,000 cycles.  In contrast, the crosslink treated samples demonstrated 
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few changes even after 8,000 cycles.  A statistically significant increase in specimen 
height of 5.5% was observed after 8,000 cycles (Figure 15). 
 
Table 3 . Properties of the gelatin specimens. * Denotes significant difference after 
cycling, p<0.05.  
  
Swell 
Ratio 
Height 
(mm) 
Hysteresis 
(N*mm) 
Secant 
Compliance 
(mm/N) 
control 
     
 
Initial 1799 6.467 74160 13.40 
 
after   
1,000 cycles 1496* 3.256* 9620* 4.79* 
     
 
genipin 
treated 
    
 
 
initial 988 7.842  5376 0.750 
 
after  
8,000 cycles 1064 8.267* 5065 0.656 
 
4.3.2. Annulus Fibrosus 
All treatment groups were successfully tested for 10,000 cycles.   
 
Annulus samples not receiving crosslinking treatment did not retain their initial lamellar 
appearance (Figure 16) and demonstrated more fluid like behavior after testing. For 
example, outside of the bath these samples did not maintain their shape.  Trypsin treated 
samples demonstrated even greater loss of lamellar structure and increased fluid like 
behavior.  Crosslinked annulus samples generally retained their lamellar appearance and 
behaved in a more solid-like manner.  For example, outside of the bath these samples did 
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maintain their shape.  After cycling, specimen diameter subjectively appeared less 
circular than initially, with elongation of the diameter occurring along an axis normal to 
the lamella plane. The observed elongation appeared greatest in the trypsin treated 
specimens, least in the crosslinked specimens and control specimen elongation appeared 
in between the trypsin and crosslinked specimens. 
4.3.3. Height 
At 5,000 and 10,000 cycles, all specimens demonstrated very large decreases in 
unloaded normalized height (Figure 17).  Control specimen normalized heights were 
0.46 after 5k cycles and 0.40 (p<.05) after 10k cycles.  Genipin-only specimen 
normalized heights during cycling were 0.64 at 5k cycles and 0.57 (p<.05) at 10k cycles.  
Relative to control specimens, genipin height was 41.9% larger than controls after 5K 
cycles and 44.2% larger after 10K cycles.  Trypsin-only specimen normalized heights 
during cycling were 0.24 at 5k cycles and 0.23 (p<.05) at 10k cycles.  Relative to control 
specimens, trypsin height was 40.9% smaller than controls after 5K cycles and 35.5% 
smaller after 10K cycles.  Combinations of genipin and trypsin together demonstrated 
height loss during cycling similar to controls and in between genipin and trypsin 
specimens.  Trypsin followed by genipin treated specimen normalized height relative to 
controls was 11.5% smaller after 5K cycles and 7.1% smaller after 10K cycles.  Genipin 
followed by trypsin treated specimen normalized height relative to control samples was 
6.2% larger after 5K cycles and 13.5% larger after 10K cycles. 
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Figure 15 Change in Specimen height of gelatin samples with cyclic mechanical 
loading. 
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Figure 16.  Example of specimens receiving trypsin treatment (left column) and 
genipin crosslink treatment (right column), before mechanical cycling (top row), 
and after 10,000 cycles with recovery soak (middle and bottom rows). 
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After overnight soaking, control specimen normalized height was 0.91.  For genipin 
treated samples, normalized height after soak was 0.81 (p<0.05 compared to initial 
height) and was 10.3% less than control post soak height.  For trypsin treated specimens, 
normalized height after soak was 0.98, 7.3% larger than the control post soak height.  
Both combination treatments exhibited marked lack of recovery, with a normalized 
height after soak of 0.51 for both treatments, 44% less than control post soak height. 
 
 
Figure 17.  Effect of mechanical and enzymatic degradation on annulus normalized 
height. 
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4.3.4. Compressive Compliance 
At 5,000 and 10,000 cycles, all specimens demonstrated increases in secant compressive 
compliance (Figure 18).  Control specimen compliance was 0.105 mm/N initially, 0.188 
mm/N after 5k cycles, and 0.200 mm/N (p<.05) after 10k cycles.  Genipin-only 
compliance during cycling was .094 mm/N initially, 0.140 mm/N at 5k cycles, and 0.157 
mm/N (p<.05) at 10k cycles.  Relative to control samples, genipin sample compliance 
started 10.8% lower and was 25.6% lower after 5k cycles and 21.7% lower after 10k 
cycles.  Trypsin-only compliance during cycling was 0.166 mm/N initially, 0.239 mm/N 
at 5k cycles, and 0.245 mm/N (p<.05) at 10k cycles.  Relative to control samples, trypsin 
sample compliance started 58.1% higher (p<0.05) and changed to 26.9% higher after 5k 
cycles and 22.8% higher after 10k cycles.  Combinations of genipin and trypsin together 
demonstrated compliance loss during cycling in between that of genipin only and trypsin 
treated specimens.  Trypsin followed by genipin treated specimen compliance started 
42.6% higher than control specimens and changed to 3.7% larger after 5k cycles and 
0.1% lower after 10k cycles.  Genipin followed by trypsin treated specimen compliance 
started 12.2% larger than control specimens and changed to 8.8% lower after 5k cycles 
and 11.6% lower after 10k cycles. 
 
After overnight soaking (Figure 18), control specimen compliance was 0.116 mm/N.  
Genipin post soak compliance was 0.119 mm/N, 2.5% larger than post soak control 
compliance.  Trypsin post soak compliance was 0.175 mm/N, 51.1% lower than post 
soak control compliance.  Combination treatments of trypsin and genipin had post soak 
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compliance values of 0.168 mm/N and 0.166 mm/N and were 45.1% and 43.4% larger 
than control post soak compliance. 
 
 
Figure 18. Effect of mechanical and enzymatic degradation on annulus compliance 
(mm/N). 
 
4.4. Discussion 
Effects to the mechanical behavior of both collagen based gelatin and bovine disc 
annulus after biochemical degradation, cyclic mechanical compression, and crosslinking 
treatment with genipin were studied.  Gelatin samples treated with genipin crosslinking 
were observed to have greatly increased resistance to degradation, with only minor 
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degradation occurring after 8,000 cycles.  Annulus samples experienced large changes in 
geometry and compliance consistent with visual observations of induced degradation 
during cycling.  Biochemical degradation with trypsin increased the magnitude of 
changes, while crosslinking with genipin resisted changes. Changes to height and 
compliance during cycling appeared to be mostly recovered after unloaded, overnight 
soaking. 
4.4.1. Gelatin Specimens 
In contrast to control samples, crosslink treated gelatin samples were successfully loaded 
in cyclic compression for 8,000 cycles at 37 °C, with the only detectable change being a 
5.5% increase in sample height.  Since this increase in height was accompanied by an 
increase in swell ratio of 2% (not significant) and is consistent with observations of 
increased swell in articular cartilage after mechanical degradation Bank 8, it seems likely 
that the samples experienced some matrix degradation from the mechanical cyclic 
compressive loading.  Interpolating the 5.5% height change observed in the crosslinked 
specimens to the control specimens suggests the controls would have reached the same 
percent change in height in 69 cycles; thus, the crosslinking treatment increased the 
degradation resistance of the gelatin samples more than 100-fold even without 
considering the 10°C drop in bath temperature. 
4.4.2. Annulus Specimens 
4.4.2.1. Effects of Biochemical Treatments Before Cyclic Degradation 
For genipin-only treatments, there was no significant difference in the initial axial 
compressive secant compliance compared to controls while trypsin-only treated 
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specimens did demonstrate a significantly increased compliance 58% larger than the 
controls.  Trypsin was previously shown by Kuo 75 to decrease dynamic stiffness 
modulus of the disc.  Crosslinking has shown mixed results to affect various stiffness 
measurements.  Slusaraewicz 108 showed a significant increase in circumferential tensile 
modulus after treatment with MG, but no significant difference after treatment with GP.  
Yeramalli 150 showed no significant difference in axial tension or compression modulus.  
Chuang 23 reported significant differences in high stiffness modulus in circumferential 
tension, but not high stiffness axial compression 
 
Treatment levels of genipin and trypsin were taken from literature reports demonstrating 
differences in tissue behavior, and there were observable differences between treatments 
with cycling.  The overnight soakings clearly influence hydration (which therefore alters 
the mechanical behavior) and were implemented first to assure that enough genipin 
could enter the matrix to effectively crosslink the entire matrix and second to minimize 
transient swelling effects that would have occurred if the specimens were placed in the 
bath for testing without first approaching hydration equilibrium.  As both crosslinking 
and chemical degradation have been shown to influence tissue hydration 16,26,97,128,148  it 
is possible that differences in initial compliance after genipin treatment were 
overshadowed due to changes in hydration that accompanied the crosslinking treatment.     
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4.4.2.2. Effects of Biochemical Degradation During Cyclic Compression 
Cyclic mechanical compression of the control specimens produced a significant 
reduction in normalized height and increased compliance relative to initial values.  
Additionally, subjective observations of the specimen shape were that the specimen 
diameter tended to distort along an axis normal to the lamella plane and is consistent 
with observations reported by Urban 132 regarding the anisotropy of annulus swelling.  
The visual appearance also suggested decreased structure of the lamellae and fibers.   
 
All specimens, regardless of treatment, showed decreased height with cycling.  Genipin 
treated specimens showed less loss of height compared to controls and visually appeared 
to better resist degradation during cycling as the structure of the lamella was intact after 
cycling.  Resistance to height loss was consistent with both increased matrix integrity  
and increased fluid retention (relative to controls), and both are effects consistent with 
changes that have been reported previously for crosslinked tissue 11,16,108,128,140 . It was 
interesting to note that the difference in height of the genipin treated specimens persisted 
for all 10,000 cycles.   
 
Trypsin treated specimens showed greater loss of height compared to controls and 
visually appeared to degrade more with mechanical cycling as indicated by the loss of 
lamella structure and increase in amorphous appearance.  Increased height loss was 
consistent with both decreased matrix integrity and decreased fluid retention, both 
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effects consistent with changes that have been reported previously for chemically 
degraded tissue 75,97,148.  
 
Although the behavior of the genipin treated samples during cycling suggests higher 
fluid retention than controls and the behavior of trypsin treated samples suggests less 
fluid retention, we did not specifically measure water content of the specimens, nor the 
degree to which loading-induced loss of matrix integrity (observed visually) would 
contribute to the loss of fluid with continued cyclic loading.  Any loading-induced 
matrix degradation would be expected to allow a greater imbibition of water during the 
final unloaded soaking, such that the near-initial height and compliance following the 
final free-soak could be the result of hyper-hydration of the cycled tissue.   Figure 3 and 
similar visual observations appear to confirm this hyper-hydration and increase in 
volume in the control and typsin treated specimens after post-cycling re-soaking. 
 
Further, without measurements of hydraulic permeability or proteoglycan concentration 
there can be no delineation as to the contribution of the mechanisms by which genipin or 
trypsin treated samples exhibited changes in fluid retention compared to controls.  
Combinations of trypsin and genipin resulted in similar height and compliance changes 
during cycling as was seen in the control specimens suggesting that the crosslink 
augmentation effect approximately balanced the enzymatic degradation effect.  
However, for combination treatments, the change in compliance after recovery was more 
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similar to the effect seen in the trypsin only treatment than in the controls or genipin 
treatments. 
4.4.2.3. Effects of Biochemical Treatments after Cyclic Degradation and 
Recovery Soak 
Control specimen normalized height recovered to 90% of initial height after unloaded 
soaking and compliance remained 10.4% larger than initial, though neither change was 
significantly different from the initial control specimen values.  If the annulus specimens 
degraded like the gelatin specimens, a slight increase in specimen height after the 
recovery soak would be expected.  However, the large changes in height during cycling 
as well as visual observations of the large changes in diameter suggest the annulus 
specimens behaved differently than the gelatin specimens.  Other studies have noted loss 
of disc height 78,79 and others increased stiffness 65 during compression testing of the 
IVD.   Conversely, Iatridis 63 reported that cyclic tension of annulus fibrosus produced a 
significant increase of 9% in recovered, normalized length.  Compression testing may be 
less sensitive at detecting degradation induced matrix expansion in the axial direction 
because the compressive load acts to deform the matrix in the opposite direction of the 
degradation induced expansion and the resulting loss of lamella structure into a more 
amorphous shape consistent with radial expansion that may have been at the expense of 
specimen height. 
 
After soaking, trypsin group specimen height recovered to 95% of initial height, which 
was 6% more than the height recovery of controls, suggesting greater fluid reabsorption 
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than in the controls.  Such an effect is consistent with increased hydraulic permeability 
allowing more fluid to re-enter the matrix during the soak, and consistent with a general 
loss of matrix integrity that decreases fiber tension, decreases fiber alignment, and 
allows expansion and distortion of the matrix, both of which were suggested as the 
mechanisms for changes in specimen height during cycling.  Further, trypsin specimen 
compliance remained 5.5% larger than the trypsin initial compliance, but this was not 
significant.   
 
After soaking, genipin treatment group specimens only recovered 81% of their initial 
height, which was significant and also 10% less than control specimen height recovery, 
suggesting less fluid reabsorption in the genipin treated specimens than in controls.  
Other studies have reported increased permeability and proteoglycan retention with 
genipin treatment 24,128 suggesting the genipin specimens would have absorbed as much 
or more fluid than controls, but with no measurements of hydraulic permeability or 
proteoglycan concentration or matrix degradation of the controls there can be no 
confirmation of whether these parameters were altered in this study or how they may 
have affected recovery.  One explanation for this difference in fluid absorption could be 
less resistance to fluid inflow in controls due to somewhat greater cycling induced 
degradation and perhaps compaction of the matrix compared to genipin treated 
specimens.  Another possible explanation for a difference is that the genipin samples 
continued to form crosslinks during the cycling and that this additional crosslinking 
restricted the matrix geometry from returning to the initial height.   
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For combination genipin-trypsin treatments, the recovery soak was much less effective 
at restoring height and compliance with large differences remaining for both 
combination treatments.  Because all three treatments containing genipin displayed lack 
of height recovery, we considered that there could have been additional crosslinking that 
occurred while the specimen was deformed from the cycling.  Sources of additional 
crosslinking activity could arise from unreacted crosslinking agent that remained in the 
matrix or from incomplete crosslink chains.  As loading altered the matrix geometry the 
distances between available bonding sites could have decreased to allow further 
crosslinking of the incomplete chains, or as the matrix denatured under the cyclic 
loading 25 access to new crosslinking sites could have been exposed.   Treatments 
including trypsin with genipin would be expected to have greater additional crosslinking 
since the trypsin degradation would have exposed even more potential crosslinking sites 
and weaken the matrix allowing greater deformation.  In fact, the two genipin-trypsin 
combinations did show the greatest unrecoverable height loss.   
4.4.2.4. Potential of Additional Crosslinking During Cycling 
To test if additional crosslinking may have formed after the initial crosslinking soak, two 
additional trypsin + genipin samples were prepared and then treated with a soak in 
excess glycine.  The glycine was used to attach to potential crosslinking sites in order to 
limit additional crosslink formation.  The percentage of recovered height for the two 
glycine treated specimens was 63% which was greater than the 51% height recovery 
observed in the trypsin + genipin treated samples without glycine.  The 12% increased 
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height recovery achieved after the glycine treatment is quite similar to the 10% 
difference in control specimens and the genipin only treatment group which supports the 
hypothesis that glycine may have blocked further crosslinking.  However, it does not 
appear to account for all of the unrecovered height in the combination treatments. 
 
4.5. Conclusion 
Effects to the mechanical behavior of bovine disc annulus after biochemical degradation, 
cyclic mechanical compression, and crosslinking treatment with genipin were studied.  
Accelerated cyclic loading to 10,000 cycles with and without biochemical treatments 
produced large changes in specimen height and compliance during cycling.  Both height 
and axial secant compliance of mechanically cycled but not biochemically treated 
samples recovered to 10% of initial values after unloaded, overnight soaking.  
Compressive loading with biochemical degradation by trypsin was observed to alter the 
mechanical behavior under compressive loading producing more severe loss of height, 
and increased compliance, relative to control specimens.  With genipin crosslinking, 
compressive loading produced less loss of height and less increase compliance relative 
to control specimens.  Recovery of genipin specimen height and compliance was 
hampered, possibly by a continuation of crosslinking that constrained matrix expansion 
and restricted fluid inflow.  
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5. CHANGES IN THE INTERFACIAL SHEAR RESISTANCE OF DISC 
ANNULUS FIBROSUS FROM GENIPIN CROSSLINKING 
 
5.1. Introduction 
The gross anatomy of the annulus fibrosis has been classically described to consist of 
concentric lamella composed of parallel collagen fibers with orientation that alters from 
adjacent lamella 28.  Tear like defects in the annulus fibrosis of the intervertebral disc are 
classified usually by location and direction of the tear, as in rim lesion (RL), concentric 
tear (CT), or radiating tear (RT) 136.  Such tears are common in adult human discs and 
are strongly correlated to age, with CT tears, comprised primarily of delamination of 
adjacent lamellae, being the first to appear and the most common 93,136. 
 
Mechanically, annular tears are known to affect the behavior of the annulus and motion 
segment.  Fazzalari 36 described decreased stiffness in lateral bending and flexion with 
induced CT using a sheep model.   Thompson 126 reported that human cadaver motion 
segments containing disc lesions had decreased torsional stiffness compared to lesion 
free discs, but the ‘with lesion’ group was older than the ‘lesion free’ group.  He further 
described positive correlations between CT and flexion – extension stiffness. In addition 
to affecting mechanics, CT tears may affect other types of tears due to increased stress 
near the structural defect 44,93. 
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A direct connection between annular tears and pain has only been weakly established.  In 
Thompson’s study all cadaver donors were described as having “no history of back pain” 
and Fazzalari’s study utilized animals.  Osti 93 postulated that pain provocation during 
discography was “closely related to the presence of tears extending to the outer lamellae 
of the annulus fibrosus”.  Freemont 39 demonstrated that painful discs had more sensory 
innervation and deeper innervation than pain free discs and aged and pain free discs.  
The presence of sensory innervation near a lesion where shearing stresses are increased 
due to the structure defect 44 seems a reasonable mechanism for pain generation but has 
yet to be proven true.  Recently Weiler 143 discussed a connection between annulus 
tearing/degradation and the presence and transport of matrix metalloproteinases that are 
linked with degenerated discs and cytokines that that may cause or modulate pain.  
Nevertheless, the presence of annulus tears (or the remaining scar) is evidence of 
structural overload, and the tear itself presents a structural failure thereby meeting 
Adams 4 proposed definition for a degenerated disc. 
 
The use of exogenous crosslinking to modulate tissue and biomaterial properties has 
been described for use in engineering scaffolds 76, bioprosthetic heart valves 7, knee 
meniscus 62, and to the weakened intervertebral disc 23,55,103 .  At the tissue level, 
increases in mechanical properties from crosslinking 108,117 increase load carrying ability 
and elongation properties of tissue and may therefore directly influence the mechanisms 
involved in tearing. 
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Recently, Gregory 47 described a method of testing the interface strength between disc 
lamella, observing that the shear stresses that lead to de-bonding are concentrated at the 
edge of the bonded interface.  The described test presents a useful tool for understanding 
interlamellar tears and their propagation.  The primary objective of the present study was 
to test if crosslinking treatment of disc annulus would increase the force needed to 
disrupt the interlamellar interface using a method similar to the one described by 
Gregory.  In addition to crosslinking increasing the disruption force, we hypothesized 
that crosslinking would increase the stiffness of the lamella interface and the work 
needed to achieve disruption. If successful, exogenous crosslinking could present as a 
therapy to minimize or prevent annular tears, assisting in the treatment of degenerated 
disc disease and back pain. 
 
5.2. Methods 
Three fresh frozen, skinned bovine tails were obtained from a local supplier.  The 
adjacent musculature was removed, and the spines stored wrapped in plastic.  While still 
frozen, the caudal disc locations were identified, cut along the mid sagittal plane, and 
then excised from the endplate with a straight razor. The nucleus was removed and the 
annulus samples placed in 0.15M PBS to soak overnight at 4°C.  The overnight free 
swelling enlarged the lamella making identification and dissection of the lamella 
interface easier.  After swelling, specimens were frozen and then while still frozen hand-
dissected using a scalpel to isolate a single inter lamella interface (Figure 19), from the 
outer half of the annulus.  Additional adjacent lamellas were maintained on both sides of 
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the interlamellar interface of the specimen to provide increased strength at the clamp 
site.  Samples were then soaked for 4 hours at 37°C in 50mM EPPS Phosphate buffer 
(ph9) (sham) or 50mM EPPS Phosphate (ph9) with 20mM genipin at 37°C (crosslink 
treated) in order to provide sufficient and uniform delivery of genipin.  After treatment, 
specimens were stored overnight at 4C in their respective solutions.  
 
 
Figure 19.  Bovine annulus specimens after dissection to isolate a single 
interlamellar interface. Note presence of multiple lamella on either side of interface 
(left photo). 
 
One disc per tail was successfully dissected into four sections and each of the four 
sections was successfully prepared producing 12 specimens from the 3 tails.  A second 
disc was taken from one tail and three samples were successfully prepared resulting in a 
total of 15 samples. To reduce inter-specimen variability, samples were paired so that 
there would be two sham and two genipin treated samples for each disc, and each 
sham/genipin pair was further grouped by size.  Of the 15 samples prepared, all were 
tested, but three failed at the clamp site and their data was not included.  It is possible 
that these samples may have been improperly dissected and contained a lamella that 
bridged between the clamping sites. 
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Mechanical testing was conducted using a Test Resources R-1000 frame with a 100N 
load cell.  Custom manufactured rake-like fixtures were used to clamp the specimens 
during testing (Figure 20).  The location of the interlamellar boundaries were marked 
with a gel pen on the lamina plane and the location of the interface midpoint was 
indicated with a gel pen on the side of the specimen.  Two digital video cameras 
monitored the specimens during testing.  From the digital video image, the stretch of the 
interlamellar interface was calculated from the position of the boundary marks.  The 
force - displacement output of the test machine was synchronized with the interlamellar 
interface stretch measured from the video by tracking the clamp positions which were 
visible in the digital video.  Specimen interface width, thickness and length were 
measured using calipers immediately before testing and force was divided by interface 
width to normalize for specimen differences and to be consistent with the analysis 
presented by Gregory.  Three preconditioning cycles were performed at 1%/sec to 10% 
strain and testing was carried out at 2%/sec to be consistent with Gregory 47. 
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Figure 20.  Lamellar interface plane view (left) showing marked interface 
boundaries (arrows) and side view (right) with mark indicating midpoint of 
interface. 
 
Using custom Octave scripts (Figure 21), stiffness was calculated by fitting a line 
through the linear region of the force (normalized by width) – displacement curve.  Yield 
force was taken at the point where there was a deviation from the linear fit of 2%.  Peak 
force was taken as the largest force from the test.  Work was calculated as the area under 
the force - displacement curve up to yield and to peak as appropriate.  Statistical 
significance was tested using the Wilcoxon Rank Sum test on the paired differences 
described for disc and size.  The Stata R11 software package was used for all statistical 
comparisons. 
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Figure 21.  Example of the force displacement data with the yield point, peak point, 
and linear region stiffness. 
 
5.3. Results 
Fifteen specimens were prepared for testing, but only twelve were successfully tested.  
Of the successfully tested specimens, six were sham treated and six were genipin treated. 
Two of the three specimens that were not successfully tested failed at the clamp site and 
one of the specimens continued to slip off the rake without failing in the interlamellar 
interface.  For the specimens whose preplanned paired counterpart was not successfully 
tested, the specimen was paired with the other treatment specimen from the same disc. 
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Table 4 summarizes the data.  The mean yield force per width was 2.43 N/mm for sham 
treated specimens, 3.87 N/mm for genipin treated specimens (59% greater than sham 
specimens), and the paired difference between the groups was 1.81 N/mm which was 
statistically significant (p<.018).  Figure 22 presents the yield force and peak force per 
width data graphically.  The mean peak force per width was 2.65 N/mm for sham treated 
specimens, 4.50 N/mm for genipin treated specimens (70% greater than sham 
specimens), and the paired difference between the groups was 2.23 N/mm which was 
statistically significant (p<.018).  The mean work to yield was 2.16 J/mm for sham 
treated specimens, 3.65 J/mm for genipin treated specimens (69% greater), and the 
paired difference between the groups was 2.38 J/mm which was statistically significant 
(p<.018).  Figure 23 presents the work to yield data graphically.   
 
 
Table 4.  The parameter measurements of the bovine lamellar interface after sham 
or genipin crosslink treatment.  Units are as follows: forces are in Newtons, force 
per width in N/mm, work per width in J/mm, stiffness in N/mm/mm, and stretch in 
mm/mm. 
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Figure 22.  Interlamellar interface force per width. * Denotes statistically 
significant difference (p<0.05) of the paired differences. 
 
Figure 23.  Interlamellar interface work to yield. * Denotes statistically significant 
difference (p<0.05) of the paired differences 
  
 83 
 
5.4. Discussion 
The purpose of this study was to determine if crosslinking treatment of the annulus 
fibrosis would increase the load bearing capability of the interlamellar interface.  
Specifically, we anticipated changes in the force and work needed to produce slip 
between the lamella and in the stiffness of the connection.  The significant increases in 
yield force per width, peak force per width, and work to yield after genipin treatment 
supports our hypothesis that crosslinking increases the load bearing capability of the 
inter lamellar interface.  Additionally, the crosslink treated samples demonstrated a 
larger mean stiffness than the control samples, but the observed difference was not 
statistically significant.  
 
The current study results demonstrate some marked differences in the sham treated 
samples compared to Gregory’s initial report47.  First, Gregory’s reported ‘load at peak’, 
which according to their description, is more closely associated to a yield force than a 
peak force, was 0.3 N/mm, approximately 8 times smaller than the  2.43 N/mm observed 
in control specimens in this study.  Gregory’s reported mean modulus value was 0.21 
N/mm2 nearly 7x smaller than the 1.46 N/mm2 of control specimens in this data set.  
Finally, we were not able to consistently identify a consistent plateau force described by 
Gregory, but most specimens did demonstrate the ability to carry load even after 
reaching peak.   
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There are many differences between this study and Gregory’s that preclude direct 
comparison of the results including the difference in species, preloading, specimen 
hydration, and geometry.  Gregory’s study used porcine cervical discs where we used 
bovine tail discs.  Gregory applied a 1400N axial compressive load for 2hr on the intact 
motion segments, which this study did not duplicate.  Such loading may have expelled 
water from the disc annulus, which would increase the difference in hydration compared 
to our soaked annulus samples.   In this study, we soaked the samples during treatment 
to provide uniform delivery of sufficient genipin to highly crosslink the tissue.  Since the 
treatment delivery was achieved with a soak, the soak to assist with identification and 
dissection of the lamella and lamella interface was also performed.  Because hydration 
has been closely linked with the mechanical behavior of the annulus fibrosis 3,46,52,63, the 
expected large difference in hydration between Gregory’s samples and those in this 
study help to at least partially explain the differences observed between the studies.   
 
Another major difference between the studies has to do with the total number of lamella 
present on either side of the interlamellar interface.  Gregory stated that their specimens 
consisted of “two intact adjacent AF layers with single-layer tabular ends” and in 
Gregory’s thesis, similar experiments are described as containing two adjacent lamella 
approximately 0.36mm thick.  Our specimens, in contrast, had on the order of 2 to 10 
extra lamella present on either side.  Initially, the extra material was expected to provide 
additional strength for clamping, but not affect the interacial shear strength.  In light of 
recent works by Schollum105 and Pezowicz99 describing a network of fibers that bridge 
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lamella, it is likely that our specimens, with the extra lamella, may have demonstrated 
greater resistance to separation due to the inter connectivity of the bridging fibers into 
the adjacent lamella.  Future testing of the lamella connections should take into account 
the interconnectivity of these bridging fibers for proper interpretation of results with 
implications for in vivo applications. 
 
The dissection techniques used to achieve a single inter lamella interface were difficult.  
A detailed dissection protocol was used to achieve a single lamella interface.  The 
dissected half-disc specimens were first allowed to free swell in PBS to enlarge the 
lamella.  After free swelling the specimens were placed on a glass slide and frozen.  
While frozen, the lamella interface to be tested was identified with the aid of oblique 
lighting, then using a sharp scalpel the lamella was carefully split on either side of the 
intended interface allowing the blade to follow the path between the lamella.   It was 
noted in early attempts to dissect specimens that as the width and length of the interface 
increased, it was more likely that the dissected specimen would contain a lamella that 
bridged between both clamp sites.  Thus the overall length and width of the interface 
were kept small and the edges of the interface were carefully inspected to ensure a clean 
cut along the lamella interface plane.    
 
To further minimize the risk of a specimen containing a bridging lamella, specimens 
were also examined immediately before testing and were further trimmed if a bridging 
lamella was suspected.  During testing, the behavior of the specimens was monitored for 
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any signs consistent with bridging fibers, especially lack of sliding in the interlamellar 
interface, very large force to failure, failure of the specimen at the clamping sites before 
sliding was observed in the interlamellar interface, or asymmetric deformation of the 
specimen during testing.  Three specimens that appeared to be properly dissected but did 
not fail in the interlamellar interface were discarded from the results. The remaining 
twelve specimens were judged to be good samples of the interlamellar interface 
mechanics. 
 
5.5. Conclusion 
In conclusion, this study has demonstrated that genipin crosslinking of the annulus 
fibrosis increases the load carrying capability of the inter-lamellar interface.  Significant 
increases were noted in yield force per width, peak force per width, and resilience (work 
to yield) associated with the disruption of adjacent lamella after crosslinking treatment.  
Additionally, a non-statistically significant trend was observed for increased stiffness 
with crosslinking treatment.  Future testing should take into account the possible effects 
of bridging fibers through adjacent lamella to better characterize the inter lamella 
interface properties.  For example, it may be beneficial to characterize interface strength 
as a function of the number of adjacent lamella or as a function of bridging fiber density.  
These results may have implications for an injectable exogenous crosslinking approach 
to treatment of intervertebral discs to increase the resistance to the initiation and 
propagation of concentric tears. 
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6. SUMMARY AND CONCLUSIONS 
 
6.1. Effects of Various Crosslinkers on Tensile Properties of the Disc Annulus 
Using different crosslinking agents in individually optimized formulations, differences 
in the circumferential tensile test properties of the disc annulus were observed.  Overall 
the trend was for the tensile parameters to increase after crosslinking treatment and the 
changes were unique to the formulations applied. 
 
N-Ethyl-N’-(3-dimethylaminopropyl carbodiimide), or EDC, produced the largest 
changes (over 300%) of any crosslinker.  However, while there where very large 
changes observed in yield stress and resilience for EDC there was a proportionately 
smaller change in stiffness.  Glutaraldehyde, one of the more commonly reported 
crosslinkers, demonstrated an increase in stiffness, but a decrease in the other measured 
parameters relative to control samples.  Genipin produced more uniform changes with 
yield stress, yield strain, resilience, and peak modulus all changing in the range of 123% 
to 166%.  Combined with a relatively lower cytotoxity, genipin appears to be a 
promising agent for affecting uniform increases in tensile mechanical properties.   
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6.2. Dose Response Relationship Between Disc Neutral Zone Stability and 
Genipin Injection Concentration 
Bilateral injections into the disc annulus with increasing concentrations of genipin 
resulted in corresponding changes in joint stability.  This data supports that a targeted 
genipin injection into the disc annulus can effectively alter its neutral zone stability. 
 
At every effective concentration, the effect to neutral zone stiffness was relatively 
greater than the effect to neutral zone length or ROM.  Injections of 20mM genipin did 
not result in a significant increase in stability for any of the metrics.  While 40mM 
injections produced significant changes in neutral zone stiffness and instability score, 
80mM injections were needed to produce significant changes to neutral zone length and 
ROM.  While the highest genipin concentration produced significant decreases in neutral 
zone length and increase in neutral zone stiffness, the changes were appreciably less than 
changes from soaking as reported by others, suggesting that further improvements in 
reagent delivery may be necessary to achieve the changes noted with soaking. 
 
6.3. Resistance of Genipin Crosslinked Annulus Fibrosus to Degradation from 
Biochemical and Mechanical Loading 
Effects to the mechanical behavior of bovine disc annulus after biochemical degradation, 
cyclic mechanical compression, and crosslinking treatment with genipin were studied.  
This study supports the hypothesis that genipin crosslinking of the annulus fibrosus 
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increases the resistance of the tissue to biochemical and mechanically induced 
degradation. 
 
Accelerated cyclic loading for 10,000 cycles with and without biochemical treatments 
produced large changes in specimen height and compliance along with visual 
observations of tissue degradation.  Cyclic loading with trypsin was observed to amplify 
the height loss and compliance increase as well as increase the visually observed 
decrease in tissue structure.  With genipin crosslinking, the effect of the cyclic loading 
was attenuated so that height loss and compliance increase were less severe and the 
visual observed tissue structure was maintained.  
 
Both height and compliance of control samples (mechanically cycled but not 
biochemically treated) recovered after unloaded, overnight soaking.  Trypsin height 
recovered relatively more than the control specimens and compliance remained 
relatively lower, consistent with matrix degradation but neither effect was significantly 
different.  Recovery of genipin specimen height and compliance was incomplete 
compared with controls, possibly by a continuation of crosslinking while compacted. 
 
6.4. Effects of Genipin Crosslinking on the Interfacial Shear Resistance of Disc 
Annulus 
The purpose of this study was to determine if crosslinking treatment of the annulus 
fibrosus would increase the load bearing capability of the interlamellar interface.  
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Significant increases were noted in yield force per width, peak force per width, and 
resilience (work to yield) associated with the disruption of adjacent lamellae after 
crosslinking treatment.  These observations support the hypothesis that crosslinking 
increases the interlamellar shear resistance of annulus fibrosus lamella.   
 
A possible dependency may exist between the observed shear properties and the total 
number of lamella present on either side of the inter-lamellar interface.  In light of recent 
works describing a network of fibers that bridge lamellae, it is likely that the current 
study specimens, with extra adjacent lamellae, may have demonstrated greater resistance 
to shear due to the inter connectivity by the bridging fibers into the adjacent lamellae. 
Future testing should take into account the possible effects of bridging fibers or the 
bridging fiber density to better characterize the inter-lamellar interface properties 
especially for in vivo application. 
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